Companies:
10,652
total market cap:
$140.732 T
Sign In
๐บ๐ธ
EN
English
$ USD
โฌ
EUR
๐ช๐บ
โน
INR
๐ฎ๐ณ
ยฃ
GBP
๐ฌ๐ง
$
CAD
๐จ๐ฆ
$
AUD
๐ฆ๐บ
$
NZD
๐ณ๐ฟ
$
HKD
๐ญ๐ฐ
$
SGD
๐ธ๐ฌ
Global ranking
Ranking by countries
America
๐บ๐ธ United States
๐จ๐ฆ Canada
๐ฒ๐ฝ Mexico
๐ง๐ท Brazil
๐จ๐ฑ Chile
Europe
๐ช๐บ European Union
๐ฉ๐ช Germany
๐ฌ๐ง United Kingdom
๐ซ๐ท France
๐ช๐ธ Spain
๐ณ๐ฑ Netherlands
๐ธ๐ช Sweden
๐ฎ๐น Italy
๐จ๐ญ Switzerland
๐ต๐ฑ Poland
๐ซ๐ฎ Finland
Asia
๐จ๐ณ China
๐ฏ๐ต Japan
๐ฐ๐ท South Korea
๐ญ๐ฐ Hong Kong
๐ธ๐ฌ Singapore
๐ฎ๐ฉ Indonesia
๐ฎ๐ณ India
๐ฒ๐พ Malaysia
๐น๐ผ Taiwan
๐น๐ญ Thailand
๐ป๐ณ Vietnam
Others
๐ฆ๐บ Australia
๐ณ๐ฟ New Zealand
๐ฎ๐ฑ Israel
๐ธ๐ฆ Saudi Arabia
๐น๐ท Turkey
๐ท๐บ Russia
๐ฟ๐ฆ South Africa
>> All Countries
Ranking by categories
๐ All assets by Market Cap
๐ Automakers
โ๏ธ Airlines
๐ซ Airports
โ๏ธ Aircraft manufacturers
๐ฆ Banks
๐จ Hotels
๐ Pharmaceuticals
๐ E-Commerce
โ๏ธ Healthcare
๐ฆ Courier services
๐ฐ Media/Press
๐ท Alcoholic beverages
๐ฅค Beverages
๐ Clothing
โ๏ธ Mining
๐ Railways
๐ฆ Insurance
๐ Real estate
โ Ports
๐ผ Professional services
๐ด Food
๐ Restaurant chains
โ๐ป Software
๐ Semiconductors
๐ฌ Tobacco
๐ณ Financial services
๐ข Oil&Gas
๐ Electricity
๐งช Chemicals
๐ฐ Investment
๐ก Telecommunication
๐๏ธ Retail
๐ฅ๏ธ Internet
๐ Construction
๐ฎ Video Game
๐ป Tech
๐ฆพ AI
>> All Categories
ETFs
๐ All ETFs
๐๏ธ Bond ETFs
๏ผ Dividend ETFs
โฟ Bitcoin ETFs
โข Ethereum ETFs
๐ช Crypto Currency ETFs
๐ฅ Gold ETFs & ETCs
๐ฅ Silver ETFs & ETCs
๐ข๏ธ Oil ETFs & ETCs
๐ฝ Commodities ETFs & ETNs
๐ Emerging Markets ETFs
๐ Small-Cap ETFs
๐ Low volatility ETFs
๐ Inverse/Bear ETFs
โฌ๏ธ Leveraged ETFs
๐ Global/World ETFs
๐บ๐ธ USA ETFs
๐บ๐ธ S&P 500 ETFs
๐บ๐ธ Dow Jones ETFs
๐ช๐บ Europe ETFs
๐จ๐ณ China ETFs
๐ฏ๐ต Japan ETFs
๐ฎ๐ณ India ETFs
๐ฌ๐ง UK ETFs
๐ฉ๐ช Germany ETFs
๐ซ๐ท France ETFs
โ๏ธ Mining ETFs
โ๏ธ Gold Mining ETFs
โ๏ธ Silver Mining ETFs
๐งฌ Biotech ETFs
๐ฉโ๐ป Tech ETFs
๐ Real Estate ETFs
โ๏ธ Healthcare ETFs
โก Energy ETFs
๐ Renewable Energy ETFs
๐ก๏ธ Insurance ETFs
๐ฐ Water ETFs
๐ด Food & Beverage ETFs
๐ฑ Socially Responsible ETFs
๐ฃ๏ธ Infrastructure ETFs
๐ก Innovation ETFs
๐ Semiconductors ETFs
๐ Aerospace & Defense ETFs
๐ Cybersecurity ETFs
๐ฆพ Artificial Intelligence ETFs
Watchlist
Account
CNA Financial
CNA
#1660
Rank
$13.23 B
Marketcap
๐บ๐ธ
United States
Country
$48.91
Share price
0.74%
Change (1 day)
7.95%
Change (1 year)
๐ฆ Insurance
๐ณ Financial services
Categories
CNA Financial Corporation
is an American financial corporation providing a broad range of standard and specialized property and casualty insurance products and services for businesses and professional.
Market cap
Revenue
Earnings
Price history
P/E ratio
P/S ratio
More
Price history
P/E ratio
P/S ratio
P/B ratio
Operating margin
EPS
Stock Splits
Dividends
Dividend yield
Shares outstanding
Fails to deliver
Cost to borrow
Total assets
Total liabilities
Total debt
Cash on Hand
Net Assets
Annual Reports (10-K)
CNA Financial
Quarterly Reports (10-Q)
Financial Year FY2025 Q3
CNA Financial - 10-Q quarterly report FY2025 Q3
Text size:
Small
Medium
Large
0000021175
12/31
2025
Q3
FALSE
CHX
FALSE
FALSE
FALSE
FALSE
http://www.cna.com/20250930#InvestmentsandDerivativesRealizedGainLoss
http://fasb.org/us-gaap/2025#OtherComprehensiveIncomeLossNetOfTax
http://www.cna.com/20250930#InvestmentsandDerivativesRealizedGainLoss
http://fasb.org/us-gaap/2025#OtherComprehensiveIncomeLossNetOfTax
http://www.cna.com/20250930#InvestmentsandDerivativesRealizedGainLoss
http://fasb.org/us-gaap/2025#OtherComprehensiveIncomeLossNetOfTax
http://www.cna.com/20250930#InvestmentsandDerivativesRealizedGainLoss
http://fasb.org/us-gaap/2025#OtherComprehensiveIncomeLossNetOfTax
http://fasb.org/us-gaap/2025#OtherCostAndExpenseOperating http://www.cna.com/20250930#Insuranceclaimsandpolicyholdersbenefitsincludingpolicyholdersdividends
http://fasb.org/us-gaap/2025#OtherCostAndExpenseOperating http://www.cna.com/20250930#Insuranceclaimsandpolicyholdersbenefitsincludingpolicyholdersdividends
http://fasb.org/us-gaap/2025#OtherCostAndExpenseOperating http://www.cna.com/20250930#Insuranceclaimsandpolicyholdersbenefitsincludingpolicyholdersdividends
http://fasb.org/us-gaap/2025#OtherCostAndExpenseOperating http://www.cna.com/20250930#Insuranceclaimsandpolicyholdersbenefitsincludingpolicyholdersdividends
http://fasb.org/us-gaap/2025#OtherCostAndExpenseOperating http://www.cna.com/20250930#Insuranceclaimsandpolicyholdersbenefitsincludingpolicyholdersdividends
P3M
P1Y
P1Y
xbrli:shares
iso4217:USD
iso4217:USD
xbrli:shares
xbrli:pure
cna:segment
0000021175
2025-01-01
2025-09-30
0000021175
exch:XNYS
2025-01-01
2025-09-30
0000021175
2025-10-30
0000021175
exch:XCHI
2025-01-01
2025-09-30
0000021175
2025-07-01
2025-09-30
0000021175
2024-07-01
2024-09-30
0000021175
2024-01-01
2024-09-30
0000021175
us-gaap:InvestmentsMember
2025-07-01
2025-09-30
0000021175
us-gaap:InvestmentsMember
2024-07-01
2024-09-30
0000021175
us-gaap:InvestmentsMember
2025-01-01
2025-09-30
0000021175
us-gaap:InvestmentsMember
2024-01-01
2024-09-30
0000021175
us-gaap:OtherInvestmentsMember
2025-07-01
2025-09-30
0000021175
us-gaap:OtherInvestmentsMember
2024-07-01
2024-09-30
0000021175
us-gaap:OtherInvestmentsMember
2025-01-01
2025-09-30
0000021175
us-gaap:OtherInvestmentsMember
2024-01-01
2024-09-30
0000021175
2025-09-30
0000021175
2024-12-31
0000021175
us-gaap:RelatedPartyMember
2025-09-30
0000021175
us-gaap:RelatedPartyMember
2024-12-31
0000021175
2023-12-31
0000021175
2024-09-30
0000021175
us-gaap:CommonStockMember
2025-06-30
0000021175
us-gaap:CommonStockMember
2024-06-30
0000021175
us-gaap:CommonStockMember
2024-12-31
0000021175
us-gaap:CommonStockMember
2023-12-31
0000021175
us-gaap:CommonStockMember
2025-09-30
0000021175
us-gaap:CommonStockMember
2024-09-30
0000021175
us-gaap:AdditionalPaidInCapitalMember
2025-06-30
0000021175
us-gaap:AdditionalPaidInCapitalMember
2024-06-30
0000021175
us-gaap:AdditionalPaidInCapitalMember
2024-12-31
0000021175
us-gaap:AdditionalPaidInCapitalMember
2023-12-31
0000021175
us-gaap:AdditionalPaidInCapitalMember
2025-07-01
2025-09-30
0000021175
us-gaap:AdditionalPaidInCapitalMember
2024-07-01
2024-09-30
0000021175
us-gaap:AdditionalPaidInCapitalMember
2025-01-01
2025-09-30
0000021175
us-gaap:AdditionalPaidInCapitalMember
2024-01-01
2024-09-30
0000021175
us-gaap:AdditionalPaidInCapitalMember
2025-09-30
0000021175
us-gaap:AdditionalPaidInCapitalMember
2024-09-30
0000021175
us-gaap:RetainedEarningsMember
2025-06-30
0000021175
us-gaap:RetainedEarningsMember
2024-06-30
0000021175
us-gaap:RetainedEarningsMember
2024-12-31
0000021175
us-gaap:RetainedEarningsMember
2023-12-31
0000021175
us-gaap:RetainedEarningsMember
2025-07-01
2025-09-30
0000021175
us-gaap:RetainedEarningsMember
2024-07-01
2024-09-30
0000021175
us-gaap:RetainedEarningsMember
2025-01-01
2025-09-30
0000021175
us-gaap:RetainedEarningsMember
2024-01-01
2024-09-30
0000021175
us-gaap:RetainedEarningsMember
2025-09-30
0000021175
us-gaap:RetainedEarningsMember
2024-09-30
0000021175
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-06-30
0000021175
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-06-30
0000021175
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-12-31
0000021175
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2023-12-31
0000021175
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-07-01
2025-09-30
0000021175
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-07-01
2024-09-30
0000021175
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-01-01
2025-09-30
0000021175
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-01-01
2024-09-30
0000021175
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-09-30
0000021175
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-09-30
0000021175
us-gaap:TreasuryStockCommonMember
2025-06-30
0000021175
us-gaap:TreasuryStockCommonMember
2024-06-30
0000021175
us-gaap:TreasuryStockCommonMember
2024-12-31
0000021175
us-gaap:TreasuryStockCommonMember
2023-12-31
0000021175
us-gaap:TreasuryStockCommonMember
2025-07-01
2025-09-30
0000021175
us-gaap:TreasuryStockCommonMember
2024-07-01
2024-09-30
0000021175
us-gaap:TreasuryStockCommonMember
2025-01-01
2025-09-30
0000021175
us-gaap:TreasuryStockCommonMember
2024-01-01
2024-09-30
0000021175
us-gaap:TreasuryStockCommonMember
2025-09-30
0000021175
us-gaap:TreasuryStockCommonMember
2024-09-30
0000021175
cna:CNAFConsolidatedMember
cna:LoewsMember
2025-09-30
0000021175
us-gaap:FixedIncomeSecuritiesMember
2025-07-01
2025-09-30
0000021175
us-gaap:FixedIncomeSecuritiesMember
2024-07-01
2024-09-30
0000021175
us-gaap:FixedIncomeSecuritiesMember
2025-01-01
2025-09-30
0000021175
us-gaap:FixedIncomeSecuritiesMember
2024-01-01
2024-09-30
0000021175
us-gaap:EquitySecuritiesMember
2025-07-01
2025-09-30
0000021175
us-gaap:EquitySecuritiesMember
2024-07-01
2024-09-30
0000021175
us-gaap:EquitySecuritiesMember
2025-01-01
2025-09-30
0000021175
us-gaap:EquitySecuritiesMember
2024-01-01
2024-09-30
0000021175
us-gaap:LimitedPartnerMember
2025-07-01
2025-09-30
0000021175
us-gaap:LimitedPartnerMember
2024-07-01
2024-09-30
0000021175
us-gaap:LimitedPartnerMember
2025-01-01
2025-09-30
0000021175
us-gaap:LimitedPartnerMember
2024-01-01
2024-09-30
0000021175
us-gaap:MortgagesMember
2025-07-01
2025-09-30
0000021175
us-gaap:MortgagesMember
2024-07-01
2024-09-30
0000021175
us-gaap:MortgagesMember
2025-01-01
2025-09-30
0000021175
us-gaap:MortgagesMember
2024-01-01
2024-09-30
0000021175
us-gaap:ShortTermInvestmentsMember
2025-07-01
2025-09-30
0000021175
us-gaap:ShortTermInvestmentsMember
2024-07-01
2024-09-30
0000021175
us-gaap:ShortTermInvestmentsMember
2025-01-01
2025-09-30
0000021175
us-gaap:ShortTermInvestmentsMember
2024-01-01
2024-09-30
0000021175
cna:TradingPortfolioSecuritiesMember
2025-07-01
2025-09-30
0000021175
cna:TradingPortfolioSecuritiesMember
2024-07-01
2024-09-30
0000021175
cna:TradingPortfolioSecuritiesMember
2025-01-01
2025-09-30
0000021175
cna:TradingPortfolioSecuritiesMember
2024-01-01
2024-09-30
0000021175
cna:OtherInvestmentIncomeMember
2025-07-01
2025-09-30
0000021175
cna:OtherInvestmentIncomeMember
2024-07-01
2024-09-30
0000021175
cna:OtherInvestmentIncomeMember
2025-01-01
2025-09-30
0000021175
cna:OtherInvestmentIncomeMember
2024-01-01
2024-09-30
0000021175
us-gaap:CommonStockMember
2025-07-01
2025-09-30
0000021175
us-gaap:CommonStockMember
2024-07-01
2024-09-30
0000021175
us-gaap:CommonStockMember
2025-01-01
2025-09-30
0000021175
us-gaap:CommonStockMember
2024-01-01
2024-09-30
0000021175
us-gaap:PreferredStockMember
2025-07-01
2025-09-30
0000021175
us-gaap:PreferredStockMember
2024-07-01
2024-09-30
0000021175
us-gaap:PreferredStockMember
2025-01-01
2025-09-30
0000021175
us-gaap:PreferredStockMember
2024-01-01
2024-09-30
0000021175
us-gaap:CorporateDebtSecuritiesMember
2025-07-01
2025-09-30
0000021175
us-gaap:CorporateDebtSecuritiesMember
2024-07-01
2024-09-30
0000021175
us-gaap:CorporateDebtSecuritiesMember
2025-01-01
2025-09-30
0000021175
us-gaap:CorporateDebtSecuritiesMember
2024-01-01
2024-09-30
0000021175
us-gaap:AssetBackedSecuritiesMember
2025-07-01
2025-09-30
0000021175
us-gaap:AssetBackedSecuritiesMember
2024-07-01
2024-09-30
0000021175
us-gaap:AssetBackedSecuritiesMember
2025-01-01
2025-09-30
0000021175
us-gaap:AssetBackedSecuritiesMember
2024-01-01
2024-09-30
0000021175
us-gaap:CorporateDebtSecuritiesMember
2025-09-30
0000021175
us-gaap:USStatesAndPoliticalSubdivisionsMember
2025-09-30
0000021175
us-gaap:ResidentialMortgageBackedSecuritiesMember
2025-09-30
0000021175
us-gaap:CommercialMortgageBackedSecuritiesMember
2025-09-30
0000021175
us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember
2025-09-30
0000021175
us-gaap:AssetBackedSecuritiesMember
2025-09-30
0000021175
us-gaap:USTreasuryAndGovernmentMember
2025-09-30
0000021175
us-gaap:ForeignGovernmentDebtSecuritiesMember
2025-09-30
0000021175
us-gaap:CorporateDebtSecuritiesMember
2024-12-31
0000021175
us-gaap:USStatesAndPoliticalSubdivisionsMember
2024-12-31
0000021175
us-gaap:ResidentialMortgageBackedSecuritiesMember
2024-12-31
0000021175
us-gaap:CommercialMortgageBackedSecuritiesMember
2024-12-31
0000021175
us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember
2024-12-31
0000021175
us-gaap:AssetBackedSecuritiesMember
2024-12-31
0000021175
us-gaap:USTreasuryAndGovernmentMember
2024-12-31
0000021175
us-gaap:ForeignGovernmentDebtSecuritiesMember
2024-12-31
0000021175
cna:ExternalCreditRatingUSGovernmentGovernmentAgenciesAndGovernmentSponsoredEnterprisesMember
2025-09-30
0000021175
cna:ExternalCreditRatingUSGovernmentGovernmentAgenciesAndGovernmentSponsoredEnterprisesMember
2024-12-31
0000021175
cna:ExternalCreditRatingAAAMember
2025-09-30
0000021175
cna:ExternalCreditRatingAAAMember
2024-12-31
0000021175
cna:ExternalCreditRatingAAMember
2025-09-30
0000021175
cna:ExternalCreditRatingAAMember
2024-12-31
0000021175
cna:ExternalCreditRatingAMember
2025-09-30
0000021175
cna:ExternalCreditRatingAMember
2024-12-31
0000021175
cna:ExternalCreditRatingBBBMember
2025-09-30
0000021175
cna:ExternalCreditRatingBBBMember
2024-12-31
0000021175
us-gaap:ExternalCreditRatingNonInvestmentGradeMember
2025-09-30
0000021175
us-gaap:ExternalCreditRatingNonInvestmentGradeMember
2024-12-31
0000021175
us-gaap:FixedIncomeSecuritiesMember
2025-09-30
0000021175
us-gaap:FixedIncomeSecuritiesMember
2024-12-31
0000021175
us-gaap:FixedIncomeSecuritiesMember
2024-09-30
0000021175
us-gaap:CorporateDebtSecuritiesMember
2025-06-30
0000021175
us-gaap:AssetBackedSecuritiesMember
2025-06-30
0000021175
2025-06-30
0000021175
us-gaap:CorporateDebtSecuritiesMember
2024-06-30
0000021175
us-gaap:AssetBackedSecuritiesMember
2024-06-30
0000021175
2024-06-30
0000021175
us-gaap:CorporateDebtSecuritiesMember
2024-09-30
0000021175
us-gaap:AssetBackedSecuritiesMember
2024-09-30
0000021175
us-gaap:CorporateDebtSecuritiesMember
2023-12-31
0000021175
us-gaap:AssetBackedSecuritiesMember
2023-12-31
0000021175
us-gaap:MortgagesMember
cna:DebtServiceCoverageRatioGreaterThanOrEqualto1.6Member
cna:DebtToValueRatioLessThan55PercentMember
2025-09-30
0000021175
us-gaap:MortgagesMember
cna:DebtServiceCoverageRatioGreaterThanOrEqualto1.6Member
cna:DebtToValueRatioEqualTo55To65PercentMember
2025-09-30
0000021175
us-gaap:MortgagesMember
cna:DebtServiceCoverageRatioGreaterThanOrEqualto1.6Member
cna:DebtToValueRatioGreaterThan65PercentMember
2025-09-30
0000021175
us-gaap:MortgagesMember
cna:DebtServiceCoverageRatioBetween1.2And1.6Member
cna:DebtToValueRatioLessThan55PercentMember
2025-09-30
0000021175
us-gaap:MortgagesMember
cna:DebtServiceCoverageRatioBetween1.2And1.6Member
cna:DebtToValueRatioEqualTo55To65PercentMember
2025-09-30
0000021175
us-gaap:MortgagesMember
cna:DebtServiceCoverageRatioBetween1.2And1.6Member
cna:DebtToValueRatioGreaterThan65PercentMember
2025-09-30
0000021175
us-gaap:MortgagesMember
cna:DebtServiceCoverageRatioLessThanOrEqualTo1.2Member
cna:DebtToValueRatioLessThan55PercentMember
2025-09-30
0000021175
us-gaap:MortgagesMember
cna:DebtServiceCoverageRatioLessThanOrEqualTo1.2Member
cna:DebtToValueRatioEqualTo55To65PercentMember
2025-09-30
0000021175
us-gaap:MortgagesMember
cna:DebtServiceCoverageRatioLessThanOrEqualTo1.2Member
cna:DebtToValueRatioGreaterThan65PercentMember
2025-09-30
0000021175
us-gaap:MortgagesMember
2025-09-30
0000021175
us-gaap:CorporateDebtSecuritiesMember
us-gaap:FairValueInputsLevel1Member
2025-09-30
0000021175
us-gaap:CorporateDebtSecuritiesMember
us-gaap:FairValueInputsLevel2Member
2025-09-30
0000021175
us-gaap:CorporateDebtSecuritiesMember
us-gaap:FairValueInputsLevel3Member
2025-09-30
0000021175
us-gaap:USStatesAndPoliticalSubdivisionsMember
us-gaap:FairValueInputsLevel1Member
2025-09-30
0000021175
us-gaap:USStatesAndPoliticalSubdivisionsMember
us-gaap:FairValueInputsLevel2Member
2025-09-30
0000021175
us-gaap:USStatesAndPoliticalSubdivisionsMember
us-gaap:FairValueInputsLevel3Member
2025-09-30
0000021175
us-gaap:AssetBackedSecuritiesMember
us-gaap:FairValueInputsLevel1Member
2025-09-30
0000021175
us-gaap:AssetBackedSecuritiesMember
us-gaap:FairValueInputsLevel2Member
2025-09-30
0000021175
us-gaap:AssetBackedSecuritiesMember
us-gaap:FairValueInputsLevel3Member
2025-09-30
0000021175
us-gaap:FairValueInputsLevel1Member
2025-09-30
0000021175
us-gaap:FairValueInputsLevel2Member
2025-09-30
0000021175
us-gaap:FairValueInputsLevel3Member
2025-09-30
0000021175
us-gaap:CommonStockMember
us-gaap:FairValueInputsLevel1Member
2025-09-30
0000021175
us-gaap:CommonStockMember
us-gaap:FairValueInputsLevel2Member
2025-09-30
0000021175
us-gaap:CommonStockMember
us-gaap:FairValueInputsLevel3Member
2025-09-30
0000021175
us-gaap:CommonStockMember
2025-09-30
0000021175
us-gaap:PreferredStockMember
us-gaap:FairValueInputsLevel1Member
2025-09-30
0000021175
us-gaap:PreferredStockMember
us-gaap:FairValueInputsLevel2Member
2025-09-30
0000021175
us-gaap:PreferredStockMember
us-gaap:FairValueInputsLevel3Member
2025-09-30
0000021175
us-gaap:PreferredStockMember
2025-09-30
0000021175
us-gaap:CorporateDebtSecuritiesMember
us-gaap:FairValueInputsLevel1Member
2024-12-31
0000021175
us-gaap:CorporateDebtSecuritiesMember
us-gaap:FairValueInputsLevel2Member
2024-12-31
0000021175
us-gaap:CorporateDebtSecuritiesMember
us-gaap:FairValueInputsLevel3Member
2024-12-31
0000021175
us-gaap:USStatesAndPoliticalSubdivisionsMember
us-gaap:FairValueInputsLevel1Member
2024-12-31
0000021175
us-gaap:USStatesAndPoliticalSubdivisionsMember
us-gaap:FairValueInputsLevel2Member
2024-12-31
0000021175
us-gaap:USStatesAndPoliticalSubdivisionsMember
us-gaap:FairValueInputsLevel3Member
2024-12-31
0000021175
us-gaap:AssetBackedSecuritiesMember
us-gaap:FairValueInputsLevel1Member
2024-12-31
0000021175
us-gaap:AssetBackedSecuritiesMember
us-gaap:FairValueInputsLevel2Member
2024-12-31
0000021175
us-gaap:AssetBackedSecuritiesMember
us-gaap:FairValueInputsLevel3Member
2024-12-31
0000021175
us-gaap:FairValueInputsLevel1Member
2024-12-31
0000021175
us-gaap:FairValueInputsLevel2Member
2024-12-31
0000021175
us-gaap:FairValueInputsLevel3Member
2024-12-31
0000021175
us-gaap:CommonStockMember
us-gaap:FairValueInputsLevel1Member
2024-12-31
0000021175
us-gaap:CommonStockMember
us-gaap:FairValueInputsLevel2Member
2024-12-31
0000021175
us-gaap:CommonStockMember
us-gaap:FairValueInputsLevel3Member
2024-12-31
0000021175
us-gaap:CommonStockMember
2024-12-31
0000021175
us-gaap:PreferredStockMember
us-gaap:FairValueInputsLevel1Member
2024-12-31
0000021175
us-gaap:PreferredStockMember
us-gaap:FairValueInputsLevel2Member
2024-12-31
0000021175
us-gaap:PreferredStockMember
us-gaap:FairValueInputsLevel3Member
2024-12-31
0000021175
us-gaap:PreferredStockMember
2024-12-31
0000021175
us-gaap:CorporateDebtSecuritiesMember
2025-06-30
0000021175
us-gaap:USStatesAndPoliticalSubdivisionsMember
2025-06-30
0000021175
us-gaap:AssetBackedSecuritiesMember
2025-06-30
0000021175
us-gaap:EquitySecuritiesMember
2025-06-30
0000021175
us-gaap:CorporateDebtSecuritiesMember
2025-07-01
2025-09-30
0000021175
us-gaap:USStatesAndPoliticalSubdivisionsMember
2025-07-01
2025-09-30
0000021175
us-gaap:AssetBackedSecuritiesMember
2025-07-01
2025-09-30
0000021175
us-gaap:EquitySecuritiesMember
2025-07-01
2025-09-30
0000021175
us-gaap:CorporateDebtSecuritiesMember
cna:OtherRevenuesMember
2025-07-01
2025-09-30
0000021175
us-gaap:USStatesAndPoliticalSubdivisionsMember
cna:OtherRevenuesMember
2025-07-01
2025-09-30
0000021175
us-gaap:AssetBackedSecuritiesMember
cna:OtherRevenuesMember
2025-07-01
2025-09-30
0000021175
us-gaap:EquitySecuritiesMember
cna:OtherRevenuesMember
2025-07-01
2025-09-30
0000021175
cna:OtherRevenuesMember
2025-07-01
2025-09-30
0000021175
us-gaap:CorporateDebtSecuritiesMember
2025-09-30
0000021175
us-gaap:USStatesAndPoliticalSubdivisionsMember
2025-09-30
0000021175
us-gaap:AssetBackedSecuritiesMember
2025-09-30
0000021175
us-gaap:EquitySecuritiesMember
2025-09-30
0000021175
us-gaap:CorporateDebtSecuritiesMember
2024-06-30
0000021175
us-gaap:USStatesAndPoliticalSubdivisionsMember
2024-06-30
0000021175
us-gaap:AssetBackedSecuritiesMember
2024-06-30
0000021175
us-gaap:EquitySecuritiesMember
2024-06-30
0000021175
us-gaap:CorporateDebtSecuritiesMember
2024-07-01
2024-09-30
0000021175
us-gaap:USStatesAndPoliticalSubdivisionsMember
2024-07-01
2024-09-30
0000021175
us-gaap:AssetBackedSecuritiesMember
2024-07-01
2024-09-30
0000021175
us-gaap:EquitySecuritiesMember
2024-07-01
2024-09-30
0000021175
us-gaap:CorporateDebtSecuritiesMember
cna:OtherRevenuesMember
2024-07-01
2024-09-30
0000021175
us-gaap:USStatesAndPoliticalSubdivisionsMember
cna:OtherRevenuesMember
2024-07-01
2024-09-30
0000021175
us-gaap:AssetBackedSecuritiesMember
cna:OtherRevenuesMember
2024-07-01
2024-09-30
0000021175
us-gaap:EquitySecuritiesMember
cna:OtherRevenuesMember
2024-07-01
2024-09-30
0000021175
cna:OtherRevenuesMember
2024-07-01
2024-09-30
0000021175
us-gaap:CorporateDebtSecuritiesMember
2024-09-30
0000021175
us-gaap:USStatesAndPoliticalSubdivisionsMember
2024-09-30
0000021175
us-gaap:AssetBackedSecuritiesMember
2024-09-30
0000021175
us-gaap:EquitySecuritiesMember
2024-09-30
0000021175
us-gaap:CorporateDebtSecuritiesMember
2024-12-31
0000021175
us-gaap:USStatesAndPoliticalSubdivisionsMember
2024-12-31
0000021175
us-gaap:AssetBackedSecuritiesMember
2024-12-31
0000021175
us-gaap:EquitySecuritiesMember
2024-12-31
0000021175
us-gaap:CorporateDebtSecuritiesMember
2025-01-01
2025-09-30
0000021175
us-gaap:USStatesAndPoliticalSubdivisionsMember
2025-01-01
2025-09-30
0000021175
us-gaap:AssetBackedSecuritiesMember
2025-01-01
2025-09-30
0000021175
us-gaap:EquitySecuritiesMember
2025-01-01
2025-09-30
0000021175
us-gaap:CorporateDebtSecuritiesMember
cna:OtherRevenuesMember
2025-01-01
2025-09-30
0000021175
us-gaap:USStatesAndPoliticalSubdivisionsMember
cna:OtherRevenuesMember
2025-01-01
2025-09-30
0000021175
us-gaap:AssetBackedSecuritiesMember
cna:OtherRevenuesMember
2025-01-01
2025-09-30
0000021175
us-gaap:EquitySecuritiesMember
cna:OtherRevenuesMember
2025-01-01
2025-09-30
0000021175
cna:OtherRevenuesMember
2025-01-01
2025-09-30
0000021175
us-gaap:CorporateDebtSecuritiesMember
2023-12-31
0000021175
us-gaap:USStatesAndPoliticalSubdivisionsMember
2023-12-31
0000021175
us-gaap:AssetBackedSecuritiesMember
2023-12-31
0000021175
us-gaap:EquitySecuritiesMember
2023-12-31
0000021175
us-gaap:CorporateDebtSecuritiesMember
2024-01-01
2024-09-30
0000021175
us-gaap:USStatesAndPoliticalSubdivisionsMember
2024-01-01
2024-09-30
0000021175
us-gaap:AssetBackedSecuritiesMember
2024-01-01
2024-09-30
0000021175
us-gaap:EquitySecuritiesMember
2024-01-01
2024-09-30
0000021175
us-gaap:CorporateDebtSecuritiesMember
cna:OtherRevenuesMember
2024-01-01
2024-09-30
0000021175
us-gaap:USStatesAndPoliticalSubdivisionsMember
cna:OtherRevenuesMember
2024-01-01
2024-09-30
0000021175
us-gaap:AssetBackedSecuritiesMember
cna:OtherRevenuesMember
2024-01-01
2024-09-30
0000021175
us-gaap:EquitySecuritiesMember
cna:OtherRevenuesMember
2024-01-01
2024-09-30
0000021175
cna:OtherRevenuesMember
2024-01-01
2024-09-30
0000021175
us-gaap:ValuationTechniqueDiscountedCashFlowMember
us-gaap:FixedIncomeSecuritiesMember
2025-09-30
0000021175
us-gaap:ValuationTechniqueDiscountedCashFlowMember
srt:MinimumMember
us-gaap:MeasurementInputCreditSpreadMember
2025-09-30
0000021175
us-gaap:ValuationTechniqueDiscountedCashFlowMember
srt:MaximumMember
us-gaap:MeasurementInputCreditSpreadMember
2025-09-30
0000021175
us-gaap:ValuationTechniqueDiscountedCashFlowMember
srt:WeightedAverageMember
us-gaap:MeasurementInputCreditSpreadMember
2025-09-30
0000021175
us-gaap:ValuationTechniqueDiscountedCashFlowMember
us-gaap:FixedIncomeSecuritiesMember
2024-12-31
0000021175
us-gaap:ValuationTechniqueDiscountedCashFlowMember
srt:MinimumMember
us-gaap:MeasurementInputCreditSpreadMember
2024-12-31
0000021175
us-gaap:ValuationTechniqueDiscountedCashFlowMember
srt:MaximumMember
us-gaap:MeasurementInputCreditSpreadMember
2024-12-31
0000021175
us-gaap:ValuationTechniqueDiscountedCashFlowMember
srt:WeightedAverageMember
us-gaap:MeasurementInputCreditSpreadMember
2024-12-31
0000021175
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2025-09-30
0000021175
us-gaap:EstimateOfFairValueFairValueDisclosureMember
us-gaap:FairValueInputsLevel1Member
2025-09-30
0000021175
us-gaap:EstimateOfFairValueFairValueDisclosureMember
us-gaap:FairValueInputsLevel2Member
2025-09-30
0000021175
us-gaap:EstimateOfFairValueFairValueDisclosureMember
us-gaap:FairValueInputsLevel3Member
2025-09-30
0000021175
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2025-09-30
0000021175
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2024-12-31
0000021175
us-gaap:EstimateOfFairValueFairValueDisclosureMember
us-gaap:FairValueInputsLevel1Member
2024-12-31
0000021175
us-gaap:EstimateOfFairValueFairValueDisclosureMember
us-gaap:FairValueInputsLevel2Member
2024-12-31
0000021175
us-gaap:EstimateOfFairValueFairValueDisclosureMember
us-gaap:FairValueInputsLevel3Member
2024-12-31
0000021175
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2024-12-31
0000021175
cna:HurricaneHeleneMember
2024-01-01
2024-09-30
0000021175
cna:SpecialtySegmentMember
cna:PropertyAndCasualtyBusinessSegmentMember
2025-07-01
2025-09-30
0000021175
cna:SpecialtySegmentMember
cna:PropertyAndCasualtyBusinessSegmentMember
2024-07-01
2024-09-30
0000021175
cna:SpecialtySegmentMember
cna:PropertyAndCasualtyBusinessSegmentMember
2025-01-01
2025-09-30
0000021175
cna:SpecialtySegmentMember
cna:PropertyAndCasualtyBusinessSegmentMember
2024-01-01
2024-09-30
0000021175
cna:CommercialSegmentMember
cna:PropertyAndCasualtyBusinessSegmentMember
2025-07-01
2025-09-30
0000021175
cna:CommercialSegmentMember
cna:PropertyAndCasualtyBusinessSegmentMember
2024-07-01
2024-09-30
0000021175
cna:CommercialSegmentMember
cna:PropertyAndCasualtyBusinessSegmentMember
2025-01-01
2025-09-30
0000021175
cna:CommercialSegmentMember
cna:PropertyAndCasualtyBusinessSegmentMember
2024-01-01
2024-09-30
0000021175
cna:InternationalSegmentMember
cna:PropertyAndCasualtyBusinessSegmentMember
2025-07-01
2025-09-30
0000021175
cna:InternationalSegmentMember
cna:PropertyAndCasualtyBusinessSegmentMember
2024-07-01
2024-09-30
0000021175
cna:InternationalSegmentMember
cna:PropertyAndCasualtyBusinessSegmentMember
2025-01-01
2025-09-30
0000021175
cna:InternationalSegmentMember
cna:PropertyAndCasualtyBusinessSegmentMember
2024-01-01
2024-09-30
0000021175
us-gaap:CorporateAndOtherMember
cna:PropertyAndCasualtyBusinessSegmentMember
2025-07-01
2025-09-30
0000021175
us-gaap:CorporateAndOtherMember
cna:PropertyAndCasualtyBusinessSegmentMember
2024-07-01
2024-09-30
0000021175
us-gaap:CorporateAndOtherMember
cna:PropertyAndCasualtyBusinessSegmentMember
2025-01-01
2025-09-30
0000021175
us-gaap:CorporateAndOtherMember
cna:PropertyAndCasualtyBusinessSegmentMember
2024-01-01
2024-09-30
0000021175
us-gaap:CorporateAndOtherMember
2025-01-01
2025-09-30
0000021175
cna:SpecialtySegmentMember
2025-01-01
2025-09-30
0000021175
cna:SpecialtySegmentMember
2025-07-01
2025-09-30
0000021175
cna:SpecialtySegmentMember
2024-07-01
2024-09-30
0000021175
cna:SpecialtySegmentMember
2024-01-01
2024-09-30
0000021175
cna:CommercialSegmentMember
2025-01-01
2025-09-30
0000021175
cna:CommercialSegmentMember
2025-07-01
2025-09-30
0000021175
cna:CommercialSegmentMember
2024-07-01
2024-09-30
0000021175
cna:CommercialSegmentMember
2024-01-01
2024-09-30
0000021175
cna:InternationalSegmentMember
2025-01-01
2025-09-30
0000021175
cna:InternationalSegmentMember
2025-07-01
2025-09-30
0000021175
cna:InternationalSegmentMember
2024-07-01
2024-09-30
0000021175
cna:InternationalSegmentMember
2024-01-01
2024-09-30
0000021175
cna:AsbestosandEnvironmentalReservesMember
2010-12-31
0000021175
cna:AsbestosandEnvironmentalReservesMember
2025-09-30
0000021175
cna:AsbestosandEnvironmentalReservesMember
2024-12-31
0000021175
us-gaap:GuaranteeObligationsMember
2025-09-30
0000021175
cna:InsuranceClaimsandPolicyholdersBenefitsIncludingPolicyholdersDividendsMember
2025-07-01
2025-09-30
0000021175
cna:InsuranceClaimsandPolicyholdersBenefitsIncludingPolicyholdersDividendsMember
2024-07-01
2024-09-30
0000021175
cna:InsuranceClaimsandPolicyholdersBenefitsIncludingPolicyholdersDividendsMember
2025-01-01
2025-09-30
0000021175
cna:InsuranceClaimsandPolicyholdersBenefitsIncludingPolicyholdersDividendsMember
2024-01-01
2024-09-30
0000021175
us-gaap:OtherOperatingIncomeExpenseMember
2025-07-01
2025-09-30
0000021175
us-gaap:OtherOperatingIncomeExpenseMember
2024-07-01
2024-09-30
0000021175
us-gaap:OtherOperatingIncomeExpenseMember
2025-01-01
2025-09-30
0000021175
us-gaap:OtherOperatingIncomeExpenseMember
2024-01-01
2024-09-30
0000021175
us-gaap:InvestmentsMember
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2025-06-30
0000021175
us-gaap:OtherInvestmentsMember
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2025-06-30
0000021175
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember
2025-06-30
0000021175
us-gaap:AociLiabilityForFuturePolicyBenefitParentMember
2025-06-30
0000021175
us-gaap:AccumulatedTranslationAdjustmentMember
2025-06-30
0000021175
us-gaap:InvestmentsMember
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2025-07-01
2025-09-30
0000021175
us-gaap:OtherInvestmentsMember
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2025-07-01
2025-09-30
0000021175
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember
2025-07-01
2025-09-30
0000021175
us-gaap:AociLiabilityForFuturePolicyBenefitParentMember
2025-07-01
2025-09-30
0000021175
us-gaap:AccumulatedTranslationAdjustmentMember
2025-07-01
2025-09-30
0000021175
us-gaap:InvestmentsMember
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2025-09-30
0000021175
us-gaap:OtherInvestmentsMember
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2025-09-30
0000021175
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember
2025-09-30
0000021175
us-gaap:AociLiabilityForFuturePolicyBenefitParentMember
2025-09-30
0000021175
us-gaap:AccumulatedTranslationAdjustmentMember
2025-09-30
0000021175
us-gaap:InvestmentsMember
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2024-06-30
0000021175
us-gaap:OtherInvestmentsMember
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2024-06-30
0000021175
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember
2024-06-30
0000021175
us-gaap:AociLiabilityForFuturePolicyBenefitParentMember
2024-06-30
0000021175
us-gaap:AccumulatedTranslationAdjustmentMember
2024-06-30
0000021175
us-gaap:InvestmentsMember
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2024-07-01
2024-09-30
0000021175
us-gaap:OtherInvestmentsMember
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2024-07-01
2024-09-30
0000021175
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember
2024-07-01
2024-09-30
0000021175
us-gaap:AociLiabilityForFuturePolicyBenefitParentMember
2024-07-01
2024-09-30
0000021175
us-gaap:AccumulatedTranslationAdjustmentMember
2024-07-01
2024-09-30
0000021175
us-gaap:InvestmentsMember
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2024-09-30
0000021175
us-gaap:OtherInvestmentsMember
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2024-09-30
0000021175
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember
2024-09-30
0000021175
us-gaap:AociLiabilityForFuturePolicyBenefitParentMember
2024-09-30
0000021175
us-gaap:AccumulatedTranslationAdjustmentMember
2024-09-30
0000021175
us-gaap:InvestmentsMember
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2024-12-31
0000021175
us-gaap:OtherInvestmentsMember
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2024-12-31
0000021175
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember
2024-12-31
0000021175
us-gaap:AociLiabilityForFuturePolicyBenefitParentMember
2024-12-31
0000021175
us-gaap:AccumulatedTranslationAdjustmentMember
2024-12-31
0000021175
us-gaap:InvestmentsMember
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2025-01-01
2025-09-30
0000021175
us-gaap:OtherInvestmentsMember
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2025-01-01
2025-09-30
0000021175
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember
2025-01-01
2025-09-30
0000021175
us-gaap:AociLiabilityForFuturePolicyBenefitParentMember
2025-01-01
2025-09-30
0000021175
us-gaap:AccumulatedTranslationAdjustmentMember
2025-01-01
2025-09-30
0000021175
us-gaap:InvestmentsMember
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2023-12-31
0000021175
us-gaap:OtherInvestmentsMember
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2023-12-31
0000021175
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember
2023-12-31
0000021175
us-gaap:AociLiabilityForFuturePolicyBenefitParentMember
2023-12-31
0000021175
us-gaap:AccumulatedTranslationAdjustmentMember
2023-12-31
0000021175
us-gaap:InvestmentsMember
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2024-01-01
2024-09-30
0000021175
us-gaap:OtherInvestmentsMember
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2024-01-01
2024-09-30
0000021175
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember
2024-01-01
2024-09-30
0000021175
us-gaap:AociLiabilityForFuturePolicyBenefitParentMember
2024-01-01
2024-09-30
0000021175
us-gaap:AccumulatedTranslationAdjustmentMember
2024-01-01
2024-09-30
0000021175
cna:PropertyAndCasualtyBusinessSegmentMember
2025-01-01
2025-09-30
0000021175
cna:LifeAndGroupAndCorporateAndOtherMember
2025-01-01
2025-09-30
0000021175
us-gaap:OperatingSegmentsMember
cna:SpecialtySegmentMember
2025-07-01
2025-09-30
0000021175
us-gaap:OperatingSegmentsMember
cna:CommercialSegmentMember
2025-07-01
2025-09-30
0000021175
us-gaap:OperatingSegmentsMember
cna:InternationalSegmentMember
2025-07-01
2025-09-30
0000021175
us-gaap:OperatingSegmentsMember
cna:LifeAndGroupNonCoreSegmentMember
2025-07-01
2025-09-30
0000021175
us-gaap:OperatingSegmentsMember
us-gaap:CorporateAndOtherMember
2025-07-01
2025-09-30
0000021175
us-gaap:IntersegmentEliminationMember
2025-07-01
2025-09-30
0000021175
us-gaap:OperatingSegmentsMember
cna:SpecialtySegmentMember
2024-07-01
2024-09-30
0000021175
us-gaap:OperatingSegmentsMember
cna:CommercialSegmentMember
2024-07-01
2024-09-30
0000021175
us-gaap:OperatingSegmentsMember
cna:InternationalSegmentMember
2024-07-01
2024-09-30
0000021175
us-gaap:OperatingSegmentsMember
cna:LifeAndGroupNonCoreSegmentMember
2024-07-01
2024-09-30
0000021175
us-gaap:OperatingSegmentsMember
us-gaap:CorporateAndOtherMember
2024-07-01
2024-09-30
0000021175
us-gaap:IntersegmentEliminationMember
2024-07-01
2024-09-30
0000021175
us-gaap:OperatingSegmentsMember
cna:SpecialtySegmentMember
2025-01-01
2025-09-30
0000021175
us-gaap:OperatingSegmentsMember
cna:CommercialSegmentMember
2025-01-01
2025-09-30
0000021175
us-gaap:OperatingSegmentsMember
cna:InternationalSegmentMember
2025-01-01
2025-09-30
0000021175
us-gaap:OperatingSegmentsMember
cna:LifeAndGroupNonCoreSegmentMember
2025-01-01
2025-09-30
0000021175
us-gaap:OperatingSegmentsMember
us-gaap:CorporateAndOtherMember
2025-01-01
2025-09-30
0000021175
us-gaap:IntersegmentEliminationMember
2025-01-01
2025-09-30
0000021175
us-gaap:OperatingSegmentsMember
cna:SpecialtySegmentMember
2025-09-30
0000021175
us-gaap:OperatingSegmentsMember
cna:CommercialSegmentMember
2025-09-30
0000021175
us-gaap:OperatingSegmentsMember
cna:InternationalSegmentMember
2025-09-30
0000021175
us-gaap:OperatingSegmentsMember
cna:LifeAndGroupNonCoreSegmentMember
2025-09-30
0000021175
us-gaap:OperatingSegmentsMember
us-gaap:CorporateAndOtherMember
2025-09-30
0000021175
us-gaap:IntersegmentEliminationMember
2025-09-30
0000021175
us-gaap:OperatingSegmentsMember
cna:SpecialtySegmentMember
2024-01-01
2024-09-30
0000021175
us-gaap:OperatingSegmentsMember
cna:CommercialSegmentMember
2024-01-01
2024-09-30
0000021175
us-gaap:OperatingSegmentsMember
cna:InternationalSegmentMember
2024-01-01
2024-09-30
0000021175
us-gaap:OperatingSegmentsMember
cna:LifeAndGroupNonCoreSegmentMember
2024-01-01
2024-09-30
0000021175
us-gaap:OperatingSegmentsMember
us-gaap:CorporateAndOtherMember
2024-01-01
2024-09-30
0000021175
us-gaap:IntersegmentEliminationMember
2024-01-01
2024-09-30
0000021175
us-gaap:OperatingSegmentsMember
cna:SpecialtySegmentMember
2024-12-31
0000021175
us-gaap:OperatingSegmentsMember
cna:CommercialSegmentMember
2024-12-31
0000021175
us-gaap:OperatingSegmentsMember
cna:InternationalSegmentMember
2024-12-31
0000021175
us-gaap:OperatingSegmentsMember
cna:LifeAndGroupNonCoreSegmentMember
2024-12-31
0000021175
us-gaap:OperatingSegmentsMember
us-gaap:CorporateAndOtherMember
2024-12-31
0000021175
us-gaap:IntersegmentEliminationMember
2024-12-31
0000021175
us-gaap:OperatingSegmentsMember
cna:ManagementandProfessionalLiabilityMember
cna:SpecialtySegmentMember
2025-07-01
2025-09-30
0000021175
us-gaap:OperatingSegmentsMember
cna:ManagementandProfessionalLiabilityMember
cna:SpecialtySegmentMember
2024-07-01
2024-09-30
0000021175
us-gaap:OperatingSegmentsMember
cna:ManagementandProfessionalLiabilityMember
cna:SpecialtySegmentMember
2025-01-01
2025-09-30
0000021175
us-gaap:OperatingSegmentsMember
cna:ManagementandProfessionalLiabilityMember
cna:SpecialtySegmentMember
2024-01-01
2024-09-30
0000021175
us-gaap:OperatingSegmentsMember
cna:SuretyMember
cna:SpecialtySegmentMember
2025-07-01
2025-09-30
0000021175
us-gaap:OperatingSegmentsMember
cna:SuretyMember
cna:SpecialtySegmentMember
2024-07-01
2024-09-30
0000021175
us-gaap:OperatingSegmentsMember
cna:SuretyMember
cna:SpecialtySegmentMember
2025-01-01
2025-09-30
0000021175
us-gaap:OperatingSegmentsMember
cna:SuretyMember
cna:SpecialtySegmentMember
2024-01-01
2024-09-30
0000021175
us-gaap:OperatingSegmentsMember
cna:WarrantyAlternativeRisksMember
cna:SpecialtySegmentMember
2025-07-01
2025-09-30
0000021175
us-gaap:OperatingSegmentsMember
cna:WarrantyAlternativeRisksMember
cna:SpecialtySegmentMember
2024-07-01
2024-09-30
0000021175
us-gaap:OperatingSegmentsMember
cna:WarrantyAlternativeRisksMember
cna:SpecialtySegmentMember
2025-01-01
2025-09-30
0000021175
us-gaap:OperatingSegmentsMember
cna:WarrantyAlternativeRisksMember
cna:SpecialtySegmentMember
2024-01-01
2024-09-30
0000021175
us-gaap:OperatingSegmentsMember
cna:MiddleMarketsMember
cna:CommercialSegmentMember
2025-07-01
2025-09-30
0000021175
us-gaap:OperatingSegmentsMember
cna:MiddleMarketsMember
cna:CommercialSegmentMember
2024-07-01
2024-09-30
0000021175
us-gaap:OperatingSegmentsMember
cna:MiddleMarketsMember
cna:CommercialSegmentMember
2025-01-01
2025-09-30
0000021175
us-gaap:OperatingSegmentsMember
cna:MiddleMarketsMember
cna:CommercialSegmentMember
2024-01-01
2024-09-30
0000021175
us-gaap:OperatingSegmentsMember
us-gaap:ConstructionMember
cna:CommercialSegmentMember
2025-07-01
2025-09-30
0000021175
us-gaap:OperatingSegmentsMember
us-gaap:ConstructionMember
cna:CommercialSegmentMember
2024-07-01
2024-09-30
0000021175
us-gaap:OperatingSegmentsMember
us-gaap:ConstructionMember
cna:CommercialSegmentMember
2025-01-01
2025-09-30
0000021175
us-gaap:OperatingSegmentsMember
us-gaap:ConstructionMember
cna:CommercialSegmentMember
2024-01-01
2024-09-30
0000021175
us-gaap:OperatingSegmentsMember
cna:SmallBusinessMember
cna:CommercialSegmentMember
2025-07-01
2025-09-30
0000021175
us-gaap:OperatingSegmentsMember
cna:SmallBusinessMember
cna:CommercialSegmentMember
2024-07-01
2024-09-30
0000021175
us-gaap:OperatingSegmentsMember
cna:SmallBusinessMember
cna:CommercialSegmentMember
2025-01-01
2025-09-30
0000021175
us-gaap:OperatingSegmentsMember
cna:SmallBusinessMember
cna:CommercialSegmentMember
2024-01-01
2024-09-30
0000021175
us-gaap:OperatingSegmentsMember
cna:OtherCommercialInsuranceMember
cna:CommercialSegmentMember
2025-07-01
2025-09-30
0000021175
us-gaap:OperatingSegmentsMember
cna:OtherCommercialInsuranceMember
cna:CommercialSegmentMember
2024-07-01
2024-09-30
0000021175
us-gaap:OperatingSegmentsMember
cna:OtherCommercialInsuranceMember
cna:CommercialSegmentMember
2025-01-01
2025-09-30
0000021175
us-gaap:OperatingSegmentsMember
cna:OtherCommercialInsuranceMember
cna:CommercialSegmentMember
2024-01-01
2024-09-30
0000021175
us-gaap:OperatingSegmentsMember
cna:CNACanadaMember
cna:InternationalSegmentMember
2025-07-01
2025-09-30
0000021175
us-gaap:OperatingSegmentsMember
cna:CNACanadaMember
cna:InternationalSegmentMember
2024-07-01
2024-09-30
0000021175
us-gaap:OperatingSegmentsMember
cna:CNACanadaMember
cna:InternationalSegmentMember
2025-01-01
2025-09-30
0000021175
us-gaap:OperatingSegmentsMember
cna:CNACanadaMember
cna:InternationalSegmentMember
2024-01-01
2024-09-30
0000021175
us-gaap:OperatingSegmentsMember
cna:CNAEuropeMember
cna:InternationalSegmentMember
2025-07-01
2025-09-30
0000021175
us-gaap:OperatingSegmentsMember
cna:CNAEuropeMember
cna:InternationalSegmentMember
2024-07-01
2024-09-30
0000021175
us-gaap:OperatingSegmentsMember
cna:CNAEuropeMember
cna:InternationalSegmentMember
2025-01-01
2025-09-30
0000021175
us-gaap:OperatingSegmentsMember
cna:CNAEuropeMember
cna:InternationalSegmentMember
2024-01-01
2024-09-30
0000021175
us-gaap:OperatingSegmentsMember
cna:HardyMember
cna:InternationalSegmentMember
2025-07-01
2025-09-30
0000021175
us-gaap:OperatingSegmentsMember
cna:HardyMember
cna:InternationalSegmentMember
2024-07-01
2024-09-30
0000021175
us-gaap:OperatingSegmentsMember
cna:HardyMember
cna:InternationalSegmentMember
2025-01-01
2025-09-30
0000021175
us-gaap:OperatingSegmentsMember
cna:HardyMember
cna:InternationalSegmentMember
2024-01-01
2024-09-30
0000021175
2025-10-01
2025-09-30
0000021175
2026-01-01
2025-09-30
0000021175
2027-01-01
2025-09-30
0000021175
2028-01-01
2025-09-30
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
10-Q
☒
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended
September 30, 2025
OR
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the transition period from _____ to _____
Commission File Number
1-5823
CNA FINANCIAL CORPORATION
(Exact name of registrant as specified in its charter)
Delaware
36-6169860
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
151 N. Franklin
60606
Chicago,
Illinois
(Zip Code)
(Address of principal executive offices)
(
312
)
822-5000
(Registrant's telephone number, including area code)
Not Applicable
(Former name, former address and former fiscal year, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, Par value $2.50
"
CNA
"
New York Stock Exchange
NYSE Texas
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes
☒
No
☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Yes
☒
No
☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer
☒
Accelerated filer
☐
Non-accelerated filer
☐
Smaller reporting company
☐
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes
☐
No
☒
As of October 30, 2025,
270,666,584
shares of common stock were outstanding.
Item Number
Page
Number
PART I
1.
Condensed Consolidated Financial Statements:
3
Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2025 and 2024 (Unaudited)
3
Condensed Consolidated Statements of Comprehensive
Income
for the three and nine months ended September 30, 2025 and 2024 (Unaudited)
4
Condensed Consolidated Balance Sheets as of September 30, 2025 and December 31, 2024 (Unaudited)
5
Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2025 and 2024 (Unaudited)
6
Condensed Consolidated Statements of Stockholders' Equity for the three and nine months ended September 30, 2025 and 2024 (Unaudited)
7
Notes to Condensed Consolidated Financial Statements (Unaudited)
8
2.
Management's Discussion and Analysis of Financial Condition and Results of Operations
45
3.
Quantitative and Qualitative Disclosures About Market Risk
68
4.
Controls and Procedures
68
PART II
1
Legal Proceedings
69
6
Exhibits
71
2
Table of Contents
PART I
Item 1. Condensed Consolidated Financial Statements
CNA Financial Corporation
Condensed Consolidated Statements of Operations (Unaudited)
Periods ended September 30
Three Months
Nine Months
(In millions, except per share data)
2025
2024
2025
2024
Revenues
Net earned premiums
$
2,783
$
2,593
$
8,103
$
7,532
Net investment income
638
626
1,904
1,853
Net investment losses
(
7
)
(
10
)
(
62
)
(
42
)
Non-insurance warranty revenue
393
401
1,188
1,212
Other revenues
10
8
28
26
Total revenues
3,817
3,618
11,161
10,581
Claims, Benefits and Expenses
Insurance claims and policyholders’ benefits (re-measurement loss of $
36
, $
48
, $
59
and $
88
)
2,032
2,019
6,144
5,708
Amortization of deferred acquisition costs
483
457
1,423
1,336
Non-insurance warranty expense
377
387
1,146
1,169
Other operating expenses
376
362
1,107
1,077
Interest expense
36
32
99
101
Total claims, benefits and expenses
3,304
3,257
9,919
9,391
Income before income tax
513
361
1,242
1,190
Income tax expense
(
110
)
(
78
)
(
266
)
(
252
)
Net income
$
403
$
283
$
976
$
938
Basic earnings per share
$
1.49
$
1.04
$
3.60
$
3.46
Diluted earnings per share
$
1.48
$
1.04
$
3.58
$
3.44
Weighted Average Outstanding Common Stock and Common Stock Equivalents
Basic
271.1
271.3
271.2
271.5
Diluted
272.3
272.7
272.4
272.7
The accompanying Notes are an integral part of these Condensed Consolidated Financial Statements (Unaudited).
3
Table of Contents
CNA Financial Corporation
Condensed Consolidated Statements of Comprehensive Income (Unaudited)
Periods ended September 30
Three Months
Nine Months
(In millions)
2025
2024
2025
2024
Comprehensive Income
Net income
$
403
$
283
$
976
$
938
Other Comprehensive Income, net of tax
Changes in:
Net unrealized gains and losses on investments with an allowance for credit losses
3
(
3
)
1
(
1
)
Net unrealized gains and losses on other investments
558
1,265
913
804
Net unrealized gains and losses on investments
561
1,262
914
803
Impact of changes in discount rates used to measure long-duration contract liabilities
(
150
)
(
623
)
(
267
)
(
9
)
Foreign currency translation adjustment
(
38
)
63
128
21
Pension and postretirement benefits
2
8
5
20
Other comprehensive income, net of tax
375
710
780
835
Total comprehensive income
$
778
$
993
$
1,756
$
1,773
The accompanying Notes are an integral part of these Condensed Consolidated Financial Statements (Unaudited).
4
Table of Contents
CNA Financial Corporation
Condensed Consolidated Balance Sheets
(In millions, except share data)
September 30, 2025 (Unaudited)
December 31, 2024
Assets
Investments:
Fixed maturity securities at fair value (amortized cost of $
44,924
and $
43,481
, less allowance for credit loss of $
61
and $
45
)
$
43,702
$
41,111
Equity securities at fair value (cost of $
688
and $
632
)
726
659
Limited partnership investments
2,713
2,520
Other invested assets
97
85
Mortgage loans (less allowance for credit loss of $
40
and $
35
)
1,055
1,019
Short-term investments
2,243
2,088
Total investments
50,536
47,482
Cash
483
472
Reinsurance receivables (less allowance for uncollectible receivables of $
22
and $
21
)
6,445
6,051
Insurance receivables (less allowance for uncollectible receivables of $
27
and $
26
)
3,666
3,671
Accrued investment income
480
451
Deferred acquisition costs
985
959
Deferred income taxes
585
850
Property and equipment at cost (less accumulated depreciation of $
342
and $
314
)
283
295
Goodwill
148
145
Deferred non-insurance warranty acquisition expense
3,340
3,525
Other assets
2,805
2,591
Total assets
$
69,756
$
66,492
Liabilities
Insurance reserves:
Claim and claim adjustment expenses
$
26,525
$
24,976
Unearned premiums
7,578
7,346
Future policy benefits
13,546
13,158
Short-term debt
500
—
Long-term debt
2,970
2,973
Deferred non-insurance warranty revenue
4,294
4,530
Other liabilities (includes $
39
and $
47
due to Loews Corporation)
3,021
2,996
Total liabilities
58,434
55,979
Commitments and contingencies (Notes C and G)
Stockholders' Equity
Common stock ($
2.50
par value;
500,000,000
shares authorized;
273,040,243
shares issued;
270,666,584
and
270,844,681
shares outstanding)
683
683
Additional paid-in capital
2,220
2,229
Retained earnings
9,739
9,686
Accumulated other comprehensive loss
(
1,211
)
(
1,991
)
Treasury stock (
2,373,659
and
2,195,562
shares), at cost
(
109
)
(
94
)
Total stockholders’ equity
11,322
10,513
Total liabilities and stockholders' equity
$
69,756
$
66,492
The accompanying Notes are an integral part of these Condensed Consolidated Financial Statements (Unaudited).
5
Table of Contents
CNA Financial Corporation
Condensed Consolidated Statements of Cash Flows (Unaudited)
Nine months ended September 30
(In millions)
2025
2024
Cash Flows from Operating Activities
Net income
$
976
$
938
Adjustments to reconcile net income to net cash flows provided by operating activities:
Deferred income tax expense
91
42
Trading portfolio activity
(
14
)
(
1
)
Net investment losses
62
42
Equity method investees
(
37
)
(
93
)
Net amortization of investments
(
149
)
(
153
)
Depreciation and amortization
53
51
Changes in:
Receivables, net
(
318
)
(
404
)
Accrued investment income
(
26
)
(
15
)
Deferred acquisition costs
(
16
)
(
45
)
Insurance reserves
1,522
1,559
Other, net
(
224
)
(
53
)
Net cash flows provided by operating activities
1,920
1,868
Cash Flows from Investing Activities
Dispositions:
Fixed maturity securities - sales
2,432
2,335
Fixed maturity securities - maturities, calls and redemptions
2,567
1,755
Equity securities
396
388
Limited partnerships
89
45
Mortgage loans
69
75
Purchases:
Fixed maturity securities
(
6,052
)
(
5,016
)
Equity securities
(
429
)
(
332
)
Limited partnerships
(
252
)
(
235
)
Mortgage loans
(
110
)
(
43
)
Change in other investments
(
5
)
(
2
)
Change in short-term investments
(
94
)
329
Purchases of property and equipment
(
58
)
(
57
)
Other, net
1
(
4
)
Net cash flows used by investing activities
(
1,446
)
(
762
)
Cash Flows from Financing Activities
Dividends paid to common stockholders
(
922
)
(
906
)
Proceeds from the issuance of debt
495
490
Repayment of debt
—
(
550
)
Purchase of treasury stock
(
34
)
(
20
)
Other, net
(
17
)
(
12
)
Net cash flows used by financing activities
(
478
)
(
998
)
Effect of foreign exchange rate changes on cash
15
3
Net change in cash
11
111
Cash, beginning of year
472
345
Cash, end of period
$
483
$
456
The accompanying Notes are an integral part of these Condensed Consolidated Financial Statements (Unaudited).
6
Table of Contents
CNA Financial Corporation
Condensed Consolidated Statements of Stockholders' Equity (Unaudited)
Periods ended September 30
Three Months
Nine Months
(In millions)
2025
2024
2025
2024
Common Stock
Balance, beginning of period
$
683
$
683
$
683
$
683
Balance, end of period
683
683
683
683
Additional Paid-in Capital
Balance, beginning of period
2,213
2,210
2,229
2,221
Stock-based compensation
7
11
(
9
)
—
Balance, end of period
2,220
2,221
2,220
2,221
Retained Earnings
Balance, beginning of period
9,460
9,623
9,686
9,755
Dividends to common stockholders ($
0.46
, $
0.44
, $
3.38
and $
3.32
per share)
(
124
)
(
121
)
(
923
)
(
908
)
Net income
403
283
976
938
Balance, end of period
9,739
9,785
9,739
9,785
Accumulated Other Comprehensive Loss
Balance, beginning of period
(
1,586
)
(
2,547
)
(
1,991
)
(
2,672
)
Other comprehensive income
375
710
780
835
Balance, end of period
(
1,211
)
(
1,837
)
(
1,211
)
(
1,837
)
Treasury Stock
Balance, beginning of period
(
109
)
(
95
)
(
94
)
(
94
)
Stock-based compensation
—
1
19
20
Purchase of treasury stock
—
—
(
34
)
(
20
)
Balance, end of period
(
109
)
(
94
)
(
109
)
(
94
)
Total stockholders' equity
$
11,322
$
10,758
$
11,322
$
10,758
The accompanying Notes are an integral part of these Condensed Consolidated Financial Statements (Unaudited).
7
Table of Contents
CNA Financial Corporation
Notes to Condensed Consolidated Financial Statements
Note A.
General
Basis of Presentation
The Condensed Consolidated Financial Statements include the accounts of CNA Financial Corporation (CNAF) and its subsidiaries. Collectively, CNAF and its subsidiaries are referred to as CNA or the Company. Loews Corporation (Loews) owned approximately
92
% of the outstanding common stock of CNAF as of September 30, 2025.
The accompanying Condensed Consolidated Financial Statements have been prepared in conformity with accounting principles generally accepted in the United States of America (GAAP). Intercompany amounts have been eliminated. Certain financial information that is normally included in annual financial statements prepared in accordance with GAAP, including certain financial statement notes, is not required for interim reporting purposes and has been condensed or omitted. These statements should be read in conjunction with the Consolidated Financial Statements and notes thereto included in CNAF's Annual Report on Form 10-K filed with the Securities and Exchange Commission (SEC) for the year ended December 31, 2024, including the summary of significant accounting policies in Note A.
The preparation of Condensed Consolidated Financial Statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the Condensed Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. Actual results may differ from those estimates.
The interim financial data as of September 30, 2025 and for the three and nine months ended September 30, 2025 and 2024 is unaudited. However, in the opinion of management, the interim data includes all adjustments, including normal recurring adjustments, necessary for a fair statement of the Company's results for the interim periods in accordance with GAAP. The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full year.
Accounting Standards Pending Adoption
In December 2023, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2023-09, Income Taxes (Topic 740):
Improvements to Income Tax Disclosures
. The updated accounting guidance requires expanded income tax disclosures, including the disaggregation of existing disclosures related to the tax rate reconciliation and income taxes paid. The guidance is effective for annual periods beginning after December 15, 2024. Therefore, for the Company, the guidance is effective for the Annual Report on Form 10-K for the year ended December 31, 2025.
In November 2024, the FASB issued ASU 2024-03, Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40):
Disaggregation of Income Statement Expenses
. The updated accounting guidance requires disaggregated disclosure of specified expense categories. The guidance also requires disclosure of total selling expenses and how the Company defines selling expenses. The guidance is effective for fiscal years beginning after December 15, 2026, and interim periods within annual periods beginning after December 15, 2027. Prospective application is required, with retrospective application permitted. The Company is currently evaluating the effect the updated guidance will have on its financial statement disclosures.
In September 2025, the FASB issued ASU No. 2025-06, Intangibles – Goodwill and Other – Internal-Use Software (Subtopic 350-40):
Targeted Improvements to the Accounting for Internal-Use Software
. The updated guidance changes the accounting for internal-use software by eliminating references to sequential project stages. Eligible software development cost capitalization will begin when: (1) management has authorized and committed to funding the software project and (2) it is probable that the software will be completed and used as intended. The guidance is effective for annual periods beginning after December 15, 2027, and interim periods within those annual periods, with early adoption permitted. The guidance may be applied using a prospective transition method, a retrospective transition method, or a modified prospective transition method. The Company is currently evaluating the effect the updated guidance will have on its financial statements.
8
Table of Contents
Note B.
Earnings Per Share Data
Earnings per share is based on weighted average number of outstanding common shares. Basic earnings per share excludes the impact of dilutive securities and is computed by dividing Net income by the weighted average number of common shares outstanding for the period. Diluted earnings per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock.
The following table presents the income and share data used in the basic and diluted earnings per share computations.
Periods ended September 30
Three Months
Nine Months
(In millions, except per share data)
2025
2024
2025
2024
Net income
$
403
$
283
$
976
$
938
Common Stock and Common Stock Equivalents
Basic
Weighted average shares outstanding
271.1
271.3
271.2
271.5
Diluted
Weighted average shares outstanding
271.1
271.3
271.2
271.5
Dilutive effect of stock-based awards under compensation plans
1.2
1.4
1.2
1.2
Total
272.3
272.7
272.4
272.7
Earnings per share
Basic
$
1.49
$
1.04
$
3.60
$
3.46
Diluted
$
1.48
$
1.04
$
3.58
$
3.44
Excluded from the calculation of diluted earnings per share is the impact of potential shares attributable to exercises or conversions into common stock under stock-based employee compensation plans that would have been antidilutive during the respective periods.
The Company repurchased
700,000
and
450,000
shares of CNAF common stock at an aggregate cost of $
34
million and $
20
million during the nine months ended September 30, 2025 and 2024.
9
Table of Contents
Note C.
Investments
The significant components of Net investment income are presented in the following table.
Periods ended September 30
Three Months
Nine Months
(In millions)
2025
2024
2025
2024
Fixed maturity securities
$
541
$
517
$
1,599
$
1,530
Equity securities
12
21
45
56
Limited partnership investments
68
67
205
195
Mortgage loans
16
14
48
43
Short-term investments
19
20
52
68
Trading portfolio
(
1
)
—
3
1
Other
5
8
19
23
Gross investment income
660
647
1,971
1,916
Investment expense
(
22
)
(
21
)
(
67
)
(
63
)
Net investment income
$
638
$
626
$
1,904
$
1,853
Net investment income (loss) recognized due to the change in fair value of common stock held as of September 30, 2025 and 2024
$
3
$
11
$
15
$
20
Net investment gains (losses) are presented in the following table.
Periods ended September 30
Three Months
Nine Months
(In millions)
2025
2024
2025
2024
Net investment gains (losses):
Fixed maturity securities:
Gross gains
$
15
$
11
$
33
$
38
Gross losses
(
25
)
(
33
)
(
100
)
(
104
)
Net investment gains (losses) on fixed maturity securities
(
10
)
(
22
)
(
67
)
(
66
)
Equity securities
4
13
10
25
Mortgage loans
—
—
(
5
)
—
Short-term investments and other
(
1
)
(
1
)
—
(
1
)
Net investment gains (losses)
$
(
7
)
$
(
10
)
$
(
62
)
$
(
42
)
Net investment gains (losses) recognized due to the change in fair value of non-redeemable preferred stock held as of September 30, 2025 and 2024
$
4
$
13
$
8
$
24
The available-for-sale impairment losses (gains) recognized in earnings by asset type are presented in the following table.
The table includes losses (gains) on securities with an intention to sell and changes in the allowance for credit losses on securities since acquisition date.
Periods ended September 30
Three Months
Nine Months
(In millions)
2025
2024
2025
2024
Fixed maturity securities available-for-sale:
Corporate and other bonds
$
4
$
8
$
15
$
23
Asset-backed
2
4
7
9
Impairment losses (gains) recognized in earnings
$
6
$
12
$
22
$
32
The Company also recognized $
5
million of impairment losses on mortgage loans during the nine months ended September 30, 2025 due to changes in expected credit losses. There were
no
impairment losses recognized on mortgage loans during the three months ended September 30, 2025 and the three and nine months ended September 30, 2024.
10
Table of Contents
The following tables present a summary of fixed maturity securities.
September 30, 2025
Cost or
Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Allowance for Credit Losses
Estimated
Fair
Value
(In millions)
Fixed maturity securities available-for-sale:
Corporate and other bonds
$
25,592
$
734
$
844
$
21
$
25,461
States, municipalities and political subdivisions
8,840
301
765
—
8,376
Asset-backed:
Residential mortgage-backed
4,041
42
382
—
3,701
Commercial mortgage-backed
1,684
19
88
22
1,593
Other asset-backed
3,790
28
190
18
3,610
Total asset-backed
9,515
89
660
40
8,904
U.S. Treasury and obligations of government-sponsored enterprises
226
—
3
—
223
Foreign government
736
10
23
—
723
Total fixed maturity securities available-for-sale
44,909
1,134
2,295
61
43,687
Total fixed maturity securities trading
15
—
—
—
15
Total fixed maturity securities
$
44,924
$
1,134
$
2,295
$
61
$
43,702
December 31, 2024
Cost or
Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Allowance for Credit Losses
Estimated
Fair
Value
(In millions)
Fixed maturity securities available-for-sale:
Corporate and other bonds
$
25,839
$
423
$
1,305
$
13
$
24,944
States, municipalities and political subdivisions
7,396
243
835
—
6,804
Asset-backed:
Residential mortgage-backed
3,725
7
488
—
3,244
Commercial mortgage-backed
1,830
11
142
18
1,681
Other asset-backed
3,770
24
239
14
3,541
Total asset-backed
9,325
42
869
32
8,466
U.S. Treasury and obligations of government-sponsored enterprises
220
1
1
—
220
Foreign government
701
6
30
—
677
Total fixed maturity securities available-for-sale
43,481
715
3,040
45
41,111
Total fixed maturity securities trading
—
—
—
—
—
Total fixed maturity securities
$
43,481
$
715
$
3,040
$
45
$
41,111
11
Table of Contents
The following tables present the estimated fair value and gross unrealized losses of available-for-sale fixed maturity securities in a gross unrealized loss position for which an allowance for credit loss has not been recorded, by the length of time in which the securities have continuously been in that position.
Less than 12 Months
12 Months or Longer
Total
September 30, 2025
Estimated
Fair Value
Gross
Unrealized
Losses
Estimated
Fair Value
Gross
Unrealized
Losses
Estimated
Fair Value
Gross
Unrealized
Losses
(In millions)
Fixed maturity securities available-for-sale:
Corporate and other bonds
$
2,802
$
58
$
8,578
$
786
$
11,380
$
844
States, municipalities and political subdivisions
701
33
3,162
732
3,863
765
Asset-backed:
Residential mortgage-backed
133
2
2,038
380
2,171
382
Commercial mortgage-backed
27
—
923
88
950
88
Other asset-backed
505
12
1,361
178
1,866
190
Total asset-backed
665
14
4,322
646
4,987
660
U.S. Treasury and obligations of government-sponsored enterprises
29
2
23
1
52
3
Foreign government
108
2
301
21
409
23
Total
$
4,305
$
109
$
16,386
$
2,186
$
20,691
$
2,295
Less than 12 Months
12 Months or Longer
Total
December 31, 2024
Estimated
Fair Value
Gross
Unrealized
Losses
Estimated
Fair Value
Gross
Unrealized
Losses
Estimated
Fair Value
Gross
Unrealized
Losses
(In millions)
Fixed maturity securities available-for-sale:
Corporate and other bonds
$
5,846
$
165
$
10,388
$
1,140
$
16,234
$
1,305
States, municipalities and political subdivisions
1,247
52
2,967
783
4,214
835
Asset-backed:
Residential mortgage-backed
849
22
2,010
466
2,859
488
Commercial mortgage-backed
230
3
988
139
1,218
142
Other asset-backed
680
21
1,557
218
2,237
239
Total asset-backed
1,759
46
4,555
823
6,314
869
U.S. Treasury and obligations of government-sponsored enterprises
49
1
41
—
90
1
Foreign government
118
3
368
27
486
30
Total
$
9,019
$
267
$
18,319
$
2,773
$
27,338
$
3,040
12
Table of Contents
The following table presents the estimated fair value and gross unrealized losses of available-for-sale fixed maturity securities in a gross unrealized loss position for which an allowance for credit loss has not been recorded, by ratings distribution.
September 30, 2025
December 31, 2024
(In millions)
Estimated Fair Value
Gross Unrealized Losses
Estimated Fair Value
Gross Unrealized Losses
U.S. Government, Government agencies and Government-sponsored enterprises
$
1,959
$
281
$
2,567
$
373
AAA
1,367
248
1,830
283
AA
3,765
633
4,257
730
A
5,049
436
6,340
582
BBB
7,846
627
11,548
980
Non-investment grade
705
70
796
92
Total
$
20,691
$
2,295
$
27,338
$
3,040
Based on current facts and circumstances, the Company believes the unrealized losses presented in the September 30, 2025 securities in a gross unrealized loss position tables above are not indicative of the ultimate collectability of the current amortized cost of the securities, but rather are primarily attributable to changes in risk-free interest rates. In reaching this determination, the Company considered the volatility in risk-free rates and credit spreads as well as the fact that its unrealized losses are concentrated in investment grade issuers. Additionally, the Company has no current intent to sell securities with unrealized losses, nor is it more likely than not that it will be required to sell prior to recovery of amortized cost; accordingly, the Company has determined that there are no additional impairment losses to be recorded as of September 30, 2025.
13
Table of Contents
The following tables present the activity related to the allowance on available-for-sale securities with credit
impairments and purchased credit-deteriorated (PCD) assets. Accrued interest receivable on available-for-sale fixed maturity securities totaled
$
469
million, $
442
million,
and $
451
million as of September 30, 2025,
December 31, 2024,
and
September 30, 2024
and is
excluded from the estimate of expected credit losses and the amortized cost basis in the tables included within this Note.
(In millions)
Corporate and other bonds
Asset-backed
Total
Allowance for credit losses:
Balance as of July 1, 2025
$
14
$
37
$
51
Additions to the allowance for credit losses:
Securities for which credit losses were not previously recorded
—
3
3
Available-for-sale securities accounted for as PCD assets
4
—
4
Reductions to the allowance for credit losses:
Securities disposed during the period (realized)
—
—
—
Intent to sell or more likely than not will be required to sell the security before recovery of its amortized cost basis
—
—
—
Write-offs charged against the allowance
—
—
—
Recoveries of amounts previously written off
—
—
—
Additional increases or (decreases) to the allowance for credit losses on securities that had an allowance recorded in a previous period
3
—
3
Balance as of September 30, 2025
$
21
$
40
$
61
(In millions)
Corporate and other bonds
Asset-backed
Total
Allowance for credit losses:
Balance as of July 1, 2024
$
—
$
17
$
17
Additions to the allowance for credit losses:
Securities for which credit losses were not previously recorded
4
—
4
Available-for-sale securities accounted for as PCD assets
2
—
2
Reductions to the allowance for credit losses:
Securities disposed during the period (realized)
—
—
—
Intent to sell or more likely than not will be required to sell the security before recovery of its amortized cost basis
—
—
—
Write-offs charged against the allowance
—
9
9
Recoveries of amounts previously written off
—
—
—
Additional increases or (decreases) to the allowance for credit losses on securities that had an allowance recorded in a previous period
—
4
4
Balance as of September 30, 2024
$
6
$
12
$
18
14
Table of Contents
(In millions)
Corporate and other bonds
Asset-backed
Total
Allowance for credit losses:
Balance as of January 1, 2025
$
13
$
32
$
45
Additions to the allowance for credit losses:
Securities for which credit losses were not previously recorded
3
3
6
Available-for-sale securities accounted for as PCD assets
4
—
4
Reductions to the allowance for credit losses:
Securities disposed during the period (realized)
6
—
6
Intent to sell or more likely than not will be required to sell the security before recovery of its amortized cost basis
—
—
—
Write-offs charged against the allowance
—
—
—
Recoveries of amounts previously written off
—
—
—
Additional increases or (decreases) to the allowance for credit losses on securities that had an allowance recorded in a previous period
7
5
12
Balance as of September 30, 2025
$
21
$
40
$
61
(In millions)
Corporate and other bonds
Asset-backed
Total
Allowance for credit losses:
Balance as of January 1, 2024
$
4
$
12
$
16
Additions to the allowance for credit losses:
Securities for which credit losses were not previously recorded
4
—
4
Available-for-sale securities accounted for as PCD assets
2
—
2
Reductions to the allowance for credit losses:
Securities disposed during the period (realized)
3
1
4
Intent to sell or more likely than not will be required to sell the security before recovery of its amortized cost basis
1
—
1
Write-offs charged against the allowance
—
9
9
Recoveries of amounts previously written off
—
—
—
Additional increases or (decreases) to the allowance for credit losses on securities that had an allowance recorded in a previous period
—
10
10
Balance as of September 30, 2024
$
6
$
12
$
18
15
Table of Contents
Contractual Maturity
The following table presents available-for-sale fixed maturity securities by contractual maturity.
September 30, 2025
December 31, 2024
(In millions)
Cost or
Amortized
Cost
Estimated
Fair
Value
Cost or
Amortized
Cost
Estimated
Fair
Value
Due in one year or less
$
1,275
$
1,267
$
1,761
$
1,753
Due after one year through five years
11,741
11,578
11,678
11,403
Due after five years through ten years
13,010
12,764
13,134
12,415
Due after ten years
18,883
18,078
16,908
15,540
Total
$
44,909
$
43,687
$
43,481
$
41,111
Actual maturities may differ from contractual maturities because certain securities may be called or prepaid. Securities not due at a single date are allocated based on weighted average life.
Investment Commitments
As part of its overall investment strategy, the Company invests in various assets which require future purchase, sale or funding commitments. These investments are recorded once funded, and the related commitments may include future capital calls from various third-party limited partnerships, signed and accepted mortgage loan applications, and obligations related to private placement securities. As of September 30, 2025, the Company had commitments to purchase or fund approximately $
1,775
million and sell approximately $
60
million under the terms of these investments.
Mortgage Loans
The following table presents the amortized cost basis of mortgage loans for each credit quality indicator by year of origination. The primary credit quality indicators utilized are debt service coverage ratios (DSCR) and loan-to-value ratios (LTV).
September 30, 2025
Mortgage Loans Amortized Cost Basis by Origination Year
(1)
(In millions)
2025
2024
2023
2022
2021
Prior
Total
DSCR ≥1.6x
LTV less than 55%
$
18
$
—
$
33
$
6
$
5
$
210
$
272
LTV 55% to 65%
—
—
12
15
6
16
49
LTV greater than 65%
—
—
—
30
12
—
42
DSCR 1.2x - 1.6x
LTV less than 55%
—
68
28
5
2
93
196
LTV 55% to 65%
55
33
38
21
19
28
194
LTV greater than 65%
23
—
—
46
—
—
69
DSCR ≤1.2
LTV less than 55%
—
—
6
34
—
21
61
LTV 55% to 65%
37
—
17
39
—
15
108
LTV greater than 65%
—
—
—
34
22
48
104
Total
$
133
$
101
$
134
$
230
$
66
$
431
$
1,095
(1) The values in the table above reflect DSCR on a standardized amortization period and LTV based on the most recent appraised values trended forward using changes in a commercial real estate price index.
As of September 30, 2025, accrued interest receivable on mortgage loans totaled $
5
million and is excluded from the amortized cost basis disclosed in the table above and the estimate of expected credit losses.
16
Table of Contents
Note D.
Fair Value
Fair value is the price that would be received upon sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The following fair value hierarchy is used in selecting inputs, with the highest priority given to Level 1, as these are the most transparent or reliable.
Level 1 - Quoted prices for identical instruments in active markets.
Level 2 - Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs are observable in active markets.
Level 3 - Valuations derived from valuation techniques in which one or more significant inputs are not observable.
Prices may fall within Level 1, 2 or 3 depending upon the methodology and inputs used to estimate fair value for each specific security. In general, the Company seeks to price securities using third-party pricing services. Securities not priced by pricing services are submitted to independent brokers for valuation and, if those are not available, internally developed pricing models are used to value assets using a methodology and inputs the Company believes market participants would use to value the assets. Prices obtained from third-party pricing services or brokers are not adjusted by the Company.
The Company performs control procedures over information obtained from pricing services and brokers to ensure prices received represent a reasonable estimate of fair value and to confirm representations regarding whether inputs are observable or unobservable. Procedures may include i) the review of pricing service methodologies or broker pricing qualifications, ii) back-testing, where past fair value estimates are compared to actual transactions executed in the market on similar dates, iii) exception reporting, where period-over-period changes in price are reviewed and challenged with the pricing service or broker based on exception criteria, and iv) deep dives, where the Company performs an independent analysis of the inputs and assumptions used to price individual securities.
17
Table of Contents
Assets and Liabilities Measured at Fair Value
Assets and liabilities measured at fair value on a recurring basis are presented in the following tables. Corporate bonds and other includes obligations of the United States of America (U.S.) Treasury, government-sponsored enterprises, foreign governments and redeemable preferred stock.
September 30, 2025
Total
Assets/Liabilities
at Fair Value
(In millions)
Level 1
Level 2
Level 3
Assets
Fixed maturity securities:
Corporate bonds and other
$
227
$
24,795
$
1,400
$
26,422
States, municipalities and political subdivisions
—
8,332
44
8,376
Asset-backed
—
7,945
959
8,904
Total fixed maturity securities
227
41,072
2,403
43,702
Equity securities:
Common stock
187
—
10
197
Non-redeemable preferred stock
36
493
—
529
Total equity securities
223
493
10
726
Short-term and other
2,017
52
—
2,069
Total assets
$
2,467
$
41,617
$
2,413
$
46,497
Total liabilities
$
—
$
—
$
—
$
—
December 31, 2024
Total
Assets/Liabilities
at Fair Value
(In millions)
Level 1
Level 2
Level 3
Assets
Fixed maturity securities:
Corporate bonds and other
$
223
$
24,340
$
1,278
$
25,841
States, municipalities and political subdivisions
—
6,762
42
6,804
Asset-backed
—
7,590
876
8,466
Total fixed maturity securities
223
38,692
2,196
41,111
Equity securities:
Common stock
162
—
18
180
Non-redeemable preferred stock
36
441
2
479
Total equity securities
198
441
20
659
Short-term and other
1,852
70
—
1,922
Total assets
$
2,273
$
39,203
$
2,216
$
43,692
Total liabilities
$
—
$
—
$
—
$
—
18
Table of Contents
The tables below present a reconciliation for all assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3).
Level 3
(In millions)
Corporate bonds and other
States, municipalities and political subdivisions
Asset-backed
Equity securities
Total
Balance as of July 1, 2025
$
1,388
$
44
$
886
$
10
$
2,328
Total realized and unrealized investment gains (losses):
Reported in Net investment gains (losses)
—
—
3
—
3
Reported in Net investment income
—
—
5
—
5
Reported in Other comprehensive income (loss)
21
—
8
—
29
Total realized and unrealized investment gains (losses)
21
—
16
—
37
Purchases
24
—
93
—
117
Sales
—
—
—
—
—
Settlements
(
33
)
—
(
36
)
—
(
69
)
Transfers into Level 3
—
—
—
—
—
Transfers out of Level 3
—
—
—
—
—
Balance as of September 30, 2025
$
1,400
$
44
$
959
$
10
$
2,413
Unrealized gains (losses) on Level 3 assets and liabilities held as of September 30, 2025 recognized in Net income (loss) in the period
$
—
$
—
$
—
$
—
$
—
Unrealized gains (losses) on Level 3 assets and liabilities held as of September 30, 2025 recognized in Other comprehensive income (loss) in the period
21
—
9
—
30
Level 3
(In millions)
Corporate bonds and other
States, municipalities and political subdivisions
Asset-backed
Equity securities
Total
Balance as of July 1, 2024
$
1,129
$
43
$
887
$
14
$
2,073
Total realized and unrealized investment gains (losses):
Reported in Net investment gains (losses)
—
—
(
3
)
—
(
3
)
Reported in Net investment income
—
—
4
—
4
Reported in Other comprehensive income (loss)
59
2
30
—
91
Total realized and unrealized investment gains (losses)
59
2
31
—
92
Purchases
83
—
38
—
121
Sales
(
10
)
—
—
—
(
10
)
Settlements
(
24
)
—
(
23
)
—
(
47
)
Transfers into Level 3
—
—
—
—
—
Transfers out of Level 3
—
—
(
18
)
—
(
18
)
Balance as of September 30, 2024
$
1,237
$
45
$
915
$
14
$
2,211
Unrealized gains (losses) on Level 3 assets and liabilities held as of September 30, 2024 recognized in Net income (loss) in the period
$
—
$
—
$
—
$
—
$
—
Unrealized gains (losses) on Level 3 assets and liabilities held as of September 30, 2024 recognized in Other comprehensive income (loss) in the period
57
2
30
—
89
19
Table of Contents
Level 3
(In millions)
Corporate bonds and other
States, municipalities and political subdivisions
Asset-backed
Equity securities
Total
Balance as of January 1, 2025
$
1,278
$
42
$
876
$
20
$
2,216
Total realized and unrealized investment gains (losses):
Reported in Net investment gains (losses)
1
—
(
1
)
2
2
Reported in Net investment income
—
—
14
(
1
)
13
Reported in Other comprehensive income (loss)
58
2
5
—
65
Total realized and unrealized investment gains (losses)
59
2
18
1
80
Purchases
123
—
142
—
265
Sales
—
—
—
(
7
)
(
7
)
Settlements
(
75
)
—
(
77
)
(
4
)
(
156
)
Transfers into Level 3
15
—
—
—
15
Transfers out of Level 3
—
—
—
—
—
Balance as of September 30, 2025
$
1,400
$
44
$
959
$
10
$
2,413
Unrealized gains (losses) on Level 3 assets and liabilities held as of September 30, 2025 recognized in Net income (loss) in the period
$
—
$
—
$
—
$
(
1
)
$
(
1
)
Unrealized gains (losses) on Level 3 assets and liabilities held as of September 30, 2025 recognized in Other comprehensive income (loss) in the period
55
2
6
—
63
Level 3
(In millions)
Corporate bonds and other
States, municipalities and political subdivisions
Asset-backed
Equity securities
Total
Balance as of January 1, 2024
$
1,045
$
44
$
901
$
24
$
2,014
Total realized and unrealized investment gains (losses):
Reported in Net investment gains (losses)
—
—
(
10
)
—
(
10
)
Reported in Net investment income
—
—
15
6
21
Reported in Other comprehensive income (loss)
39
1
14
—
54
Total realized and unrealized investment gains (losses)
39
1
19
6
65
Purchases
229
—
111
3
343
Sales
(
10
)
—
(
14
)
(
19
)
(
43
)
Settlements
(
77
)
—
(
65
)
—
(
142
)
Transfers into Level 3
11
—
—
—
11
Transfers out of Level 3
—
—
(
37
)
—
(
37
)
Balance as of September 30, 2024
$
1,237
$
45
$
915
$
14
$
2,211
Unrealized gains (losses) on Level 3 assets and liabilities held as of September 30, 2024 recognized in Net income (loss) in the period
$
—
$
—
$
—
$
2
$
2
Unrealized gains (losses) on Level 3 assets and liabilities held as of September 30, 2024 recognized in Other comprehensive income (loss) in the period
34
1
14
—
49
Securities may be transferred in or out of levels within the fair value hierarchy based on the availability of observable market information and quoted prices used to determine the fair value of the security. The availability of observable market information and quoted prices varies based on market conditions and trading volume.
20
Table of Contents
Valuation Methodologies and Inputs
The following section describes the valuation methodologies and relevant inputs used to measure different financial instruments at fair value, including an indication of the level in the fair value hierarchy in which the instruments are generally classified.
Fixed Maturity Securities
Level 1 securities include highly liquid government securities and exchange traded bonds, valued using quoted market prices. Level 2 securities include most other fixed maturity securities as the significant inputs are observable in the marketplace. All classes of Level 2 fixed maturity securities are valued using a methodology based on information generated by market transactions involving identical or comparable assets, a discounted cash flow methodology, or a combination of both when necessary. Common inputs for all classes of fixed maturity securities include prices from recently executed transactions of similar securities, marketplace quotes, benchmark yields, spreads off benchmark yields, interest rates and U.S. Treasury or swap curves. Specifically for asset-backed securities, key inputs include prepayment and default projections based on past performance of the underlying collateral and current market data. Fixed maturity securities are primarily assigned to Level 3 in cases where broker/dealer quotes are significant inputs to the valuation and there is a lack of transparency as to whether these quotes are based on information that is observable in the marketplace. Level 3 securities also include private placement debt securities whose fair value is determined using internal models with some inputs that are not market observable.
Equity Securities
Level 1 equity securities include publicly traded securities valued using quoted market prices. Level 2 securities are primarily valued using pricing for similar securities, recently executed transactions and other pricing models utilizing market observable inputs. Level 3 securities are primarily priced using broker/dealer quotes and internal models with some inputs that are not market observable.
Short-Term and Other Invested Assets
Securities that are actively traded or have quoted prices are classified as Level 1. These securities include money market funds and treasury bills. Level 2 primarily includes non-U.S. government securities for which all inputs are market observable. Fixed maturity securities purchased within one year of maturity are classified consistent with fixed maturity securities discussed above. Short-term investments as presented in the tables above differ from the amounts presented on the Condensed Consolidated Balance Sheets because certain short-term investments, such as time deposits, are not measured at fair value.
As of September 30, 2025 and December 31, 2024, there were $
90
million and $
79
million of overseas deposits within Other invested assets, which can be redeemed at net asset value in 90 days or less. Overseas deposits are excluded from the fair value hierarchy because their fair value is recorded using the net asset value per share (or equivalent) practical expedient.
21
Table of Contents
Significant Unobservable Inputs
The following tables present quantitative information about the significant unobservable inputs utilized by the Company in the fair value measurements of Level 3 assets. Valuations for assets and liabilities not presented in the tables below are primarily based on broker/dealer quotes for which there is a lack of transparency as to inputs used to develop the valuations. The quantitative detail of these unobservable inputs is neither provided nor reasonably available to the Company. The weighted average rate is calculated based on fair value.
September 30, 2025
Estimated Fair Value
(In millions)
Valuation Technique(s)
Unobservable Input(s)
Range
(Weighted Average)
Fixed maturity securities
$
1,866
Discounted cash flow
Credit spread
1
% -
7
% (
2
%)
December 31, 2024
Estimated Fair Value
(In millions)
Valuation Technique(s)
Unobservable Input(s)
Range
(Weighted Average)
Fixed maturity securities
$
1,724
Discounted cash flow
Credit spread
1
% -
6
% (
2
%)
For fixed maturity securities, an increase to the credit spread assumptions would result in a lower fair value measurement.
Financial Assets and Liabilities Not Measured at Fair Value
The carrying amount and estimated fair value of the Company's financial assets and liabilities which are not measured at fair value on the Condensed Consolidated Balance Sheets are presented in the following tables.
September 30, 2025
Carrying
Amount
Estimated Fair Value
(In millions)
Level 1
Level 2
Level 3
Total
Assets
Mortgage loans
$
1,055
$
—
$
—
$
1,047
$
1,047
Liabilities
Short-term debt
$
500
$
—
$
500
$
—
$
500
Long-term debt
2,970
—
2,959
—
2,959
December 31, 2024
Carrying
Amount
Estimated Fair Value
(In millions)
Level 1
Level 2
Level 3
Total
Assets
Mortgage loans
$
1,019
$
—
$
—
$
987
$
987
Liabilities
Short-term debt
$
—
$
—
$
—
$
—
$
—
Long-term debt
2,973
—
2,885
—
2,885
The carrying amounts reported on the Condensed Consolidated Balance Sheets for Cash, Short-term investments not carried at fair value, Accrued investment income and certain Other assets and Other liabilities approximate fair value due to the short term nature of these items. These assets and liabilities are not listed in the tables above.
22
Table of Contents
Note E.
Claim and Claim Adjustment Expense Reserves
Claim and claim adjustment expense reserves represent the estimated amounts necessary to resolve all outstanding claims, including incurred but not reported (IBNR) claims as of the reporting date. The Company's reserve projections are based primarily on detailed analysis of the facts in each case, the Company's experience with similar cases and various historical development patterns. Consideration is given to historical patterns such as claim reserving trends and settlement practices, loss payments, pending levels of unpaid claims and product mix, economic, medical and social inflation, and public attitudes. All of these factors can affect the estimation of claim and claim adjustment expense reserves.
Establishing claim and claim adjustment expense reserves, including claim and claim adjustment expense reserves for catastrophic events that have occurred, is an estimation process. Many factors can ultimately affect the final settlement of a claim and, therefore, the necessary reserve. Changes in the law, results of litigation, medical costs, the cost of repair materials and labor rates can affect ultimate claim costs. In addition, time can be a critical part of reserving determinations since the longer the span between the incidence of a loss and the payment or settlement of the claim, the more variable the ultimate settlement amount can be. Accordingly, short-tail claims, such as property damage claims, tend to be more reasonably estimable than long-tail claims, such as workers' compensation, general liability and professional liability claims. Claim and claim adjustment expense reserves are also maintained for the Company's structured settlement obligations. In developing the claim and claim adjustment expense reserve estimates for structured settlement obligations, the Company's actuaries review mortality experience on an annual basis. Adjustments to prior year reserve estimates, if necessary, are reflected in the results of operations in the period that the need for such adjustments is determined. There can be no assurance that the Company's ultimate cost for insurance losses will not exceed current estimates.
Catastrophes are an inherent risk of the property and casualty insurance business and have contributed to material period-to-period fluctuations in our results of operations and/or equity. The Company reported catastrophe losses, net of reinsurance, of $
41
million and $
200
million for the three and nine months ended September 30, 2025 driven by severe weather related events. The Company reported catastrophe losses, net of reinsurance, of $
143
million and $
313
million for the three and nine months ended September 30, 2024 driven by severe weather related events, including $
55
million for Hurricane Helene.
23
Table of Contents
Liability for Unpaid Claim and Claim Adjustment Expenses
The following table presents a reconciliation between beginning and ending claim and claim adjustment expense reserves.
For the nine months ended September 30
(In millions)
2025
2024
Reserves, beginning of year:
Gross
$
24,976
$
23,304
Ceded
5,713
5,141
Net reserves, beginning of year
19,263
18,163
Net incurred claim and claim adjustment expenses:
Provision for insured events of current year
5,011
4,706
Increase (decrease) in provision for insured events of prior years
191
26
Amortization of discount
29
30
Total net incurred
(1)
5,231
4,762
Net payments attributable to:
Current year events
(
659
)
(
655
)
Prior year events
(
3,463
)
(
3,189
)
Total net payments
(
4,122
)
(
3,844
)
Foreign currency translation adjustment and other
165
35
Net reserves, end of period
20,537
19,116
Ceded reserves, end of period
5,988
5,442
Gross reserves, end of period
$
26,525
$
24,558
(1) Total net incurred does not agree to Insurance claims and policyholders' benefits as reflected on the Condensed Consolidated Statements of Operations due to amounts related to retroactive reinsurance deferred gain accounting, uncollectible reinsurance and benefit expenses related to future policy benefits and policyholders' dividends, which are not reflected in the table above.
Net Prior Year Development
Changes in estimates of claim and claim adjustment expense reserves, net of reinsurance, for prior years are defined as net prior year loss reserve development (development). These changes can be favorable or unfavorable.
The following table presents development recorded for the Specialty, Commercial, International and Corporate & Other segments.
Periods ended September 30
Three Months
Nine Months
(In millions)
2025
2024
2025
2024
Pretax (favorable) unfavorable development:
Specialty
$
—
$
—
$
10
$
(
8
)
Commercial
(
1
)
(
3
)
46
(
11
)
International
—
(
2
)
—
(
5
)
Corporate & Other
—
22
134
57
Total pretax (favorable) unfavorable development
$
(
1
)
$
17
$
190
$
33
Unfavorable development of $
134
million was recorded within the Corporate & Other segment for the nine months ended September 30, 2025, largely associated with legacy mass tort abuse claim activity, the on-going effects of social inflation and the agreement in principle with regards to the Diocese of Rochester. Unfavorable development of $
22
million and $
57
million was recorded within the Corporate & Other segment for the three and nine months ended September 30, 2024, largely associated with legacy mass tort abuse reserves.
24
Table of Contents
Specialty
The following table presents further detail of the development recorded for the Specialty segment.
Periods ended September 30
Three Months
Nine Months
(In millions)
2025
2024
2025
2024
Pretax (favorable) unfavorable development:
Medical Professional Liability
$
—
$
—
$
—
$
(
2
)
Other Professional Liability and Management Liability
25
11
43
28
Surety
(
25
)
(
20
)
(
47
)
(
46
)
Warranty
—
7
10
20
Other
—
2
4
(
8
)
Total pretax (favorable) unfavorable development
$
—
$
—
$
10
$
(
8
)
Three Months
2025
Unfavorable development in other professional liability and management liability was primarily due to higher than expected claim severity and frequency in the Company's professional errors and omissions (E&O) business.
Favorable development in surety was primarily due to lower than expected frequency and lack of systemic activity in multiple accident years.
2024
Unfavorable development in other professional liability and management liability was primarily due to higher than expected large claim severity in the Company's directors and officers (D&O) business in accident year 2019.
Favorable development in surety was primarily due to lower than expected frequency and lack of systemic activity in multiple accident years.
Nine Months
2025
Unfavorable development in other professional liability and management liability was primarily due to higher than expected claim severity and frequency in the Company's professional E&O business.
Favorable development in surety was primarily due to lower than expected frequency and lack of systemic activity in multiple accident years.
Unfavorable development in warranty was primarily due to higher than expected frequency and severity in the most recent accident year for auto warranty.
2024
Unfavorable development in other professional liability and management liability was primarily due to higher than expected claim severity and frequency in the Company's professional E&O and cyber businesses.
Favorable development in surety was primarily due to lower than expected frequency and lack of systemic activity in multiple accident years.
Unfavorable development in warranty was primarily due to higher than expected frequency and severity in a recent accident year.
25
Table of Contents
Commercial
The following table presents further detail of the development recorded for the Commercial segment.
Periods ended September 30
Three Months
Nine Months
(In millions)
2025
2024
2025
2024
Pretax (favorable) unfavorable development:
Commercial Auto
$
—
$
25
$
50
$
46
General Liability
—
28
62
47
Workers' Compensation
(
1
)
(
57
)
(
66
)
(
106
)
Property and Other
—
1
—
2
Total pretax (favorable) unfavorable development
$
(
1
)
$
(
3
)
$
46
$
(
11
)
Three Months
2024
Unfavorable development in commercial auto was due to higher than expected claim severity in recent accident years.
Unfavorable development in general liability was due to higher than expected large claim severity in multiple accident years going back to 2015.
Favorable development in workers’ compensation was due to favorable medical trends driving lower than expected severity primarily in accident years 2018 and prior.
Nine Months
2025
Unfavorable development in commercial auto was due to higher than expected claim severity largely in the Company’s construction business in the most recent accident year.
Unfavorable development in general liability was due to higher than expected claim severity in multiple accident years going back to 2016.
Favorable development in workers’ compensation was due to favorable medical trends driving lower than expected severity in multiple accident years.
2024
Unfavorable development in commercial auto was due to higher than expected claim severity in recent accident years.
Unfavorable development in general liability was due to higher than expected large claim severity in multiple accident years going back to 2015.
Favorable development in workers’ compensation was due to favorable medical trends driving lower than expected severity primarily in accident years 2018 and prior.
26
Table of Contents
International
The following table presents further detail of the development recorded for the International segment.
Periods ended September 30
Three Months
Nine Months
(In millions)
2025
2024
2025
2024
Pretax (favorable) unfavorable development:
Commercial
$
(
1
)
$
(
13
)
$
(
4
)
$
(
7
)
Specialty
1
11
5
2
Other
—
—
(
1
)
—
Total pretax (favorable) unfavorable development
$
—
$
(
2
)
$
—
$
(
5
)
Three Months
2024
Favorable development in commercial was due to lower than expected loss emergence across multiple accident years in the Company's marine and property businesses.
Unfavorable development in specialty was due to higher than expected large loss emergence across several accident years.
27
Table of Contents
Asbestos & Environmental Pollution (A&EP) Reserves
In 2010, Continental Casualty Company (CCC) together with several of the Company’s insurance subsidiaries completed a transaction with National Indemnity Company (NICO), a subsidiary of Berkshire Hathaway Inc., under which substantially all of the Company’s legacy A&EP liabilities were ceded to NICO through a Loss Portfolio Transfer (LPT). At the effective date of the transaction, the Company ceded approximately $
1.6
billion of net A&EP claim and allocated claim adjustment expense reserves to NICO under a retroactive reinsurance agreement with an aggregate limit of $
4.0
billion. The $
1.6
billion of claim and allocated claim adjustment expense reserves ceded to NICO was net of $
1.2
billion of ceded claim and allocated claim adjustment expense reserves under existing third-party reinsurance contracts. The NICO LPT aggregate reinsurance limit also covers credit risk on the existing third-party reinsurance related to these liabilities. The Company paid NICO a reinsurance premium of $
2.0
billion and transferred to NICO billed third-party reinsurance receivables related to A&EP claims with a net book value of $
215
million, resulting in total consideration of $
2.2
billion.
In years subsequent to the effective date of the LPT, the Company recognized adverse prior year development on its A&EP reserves resulting in additional amounts ceded under the LPT. As a result, the cumulative amounts ceded under the LPT have exceeded the $
2.2
billion consideration paid, resulting in the NICO LPT moving into a gain position, requiring retroactive reinsurance accounting. Under retroactive reinsurance accounting, this gain is deferred and only recognized in earnings in proportion to actual paid recoveries under the LPT. Over the life of the contract, there is no economic impact as long as any additional losses incurred are within the limit of the LPT. In a period in which the Company recognizes a change in the estimate of A&EP reserves that increases or decreases the amounts ceded under the LPT, the proportion of actual paid recoveries to total ceded losses is affected and the change in the deferred gain is recognized in earnings as if the revised estimate of ceded losses was available at the effective date of the LPT. The effect of the deferred retroactive reinsurance benefit is recorded in Insurance claims and policyholders' benefits in the Condensed Consolidated Statements of Operations.
The impact of the LPT on the Condensed Consolidated Statements of Operations was the recognition of a retroactive reinsurance benefit of $
14
million and $
11
million for the three months ended September 30, 2025 and 2024 and $
39
million and $
36
million for the nine months ended September 30, 2025 and 2024. As of September 30, 2025 and December 31, 2024, the cumulative amounts ceded under the LPT were $
3.7
billion. The unrecognized deferred retroactive reinsurance benefit was $
386
million and $
425
million as of September 30, 2025 and December 31, 2024 and is included within Other liabilities on the Condensed Consolidated Balance Sheets.
NICO established a collateral trust account as security for its obligations to the Company. The fair value of the collateral trust account was $
2.3
billion as of September 30, 2025. In addition, Berkshire Hathaway Inc. guaranteed the payment obligations of NICO up to the aggregate reinsurance limit as well as certain of NICO’s performance obligations under the trust agreement. NICO is responsible for claims handling and billing and collection from third-party reinsurers related to the majority of the Company’s A&EP claims.
Credit Risk for Ceded Reserves
The majority of the Company’s outstanding voluntary reinsurance receivables are due from reinsurers with financial strength ratings of A- or higher. Receivables due from reinsurers with lower financial strength ratings are primarily due from captive reinsurers and are backed by collateral arrangements.
28
Table of Contents
Note F.
Future Policy Benefits Reserves
Future policy benefits reserves are associated with the Company's run-off long-term care business, which is included in the Life & Group segment, and relate to policyholders that are currently receiving benefits, including claims that have been incurred but are not yet reported, as well as policyholders that are not yet receiving benefits. Future policy benefits reserves are comprised of the liability for future policyholder benefits (LFPB) which is reflected as Insurance reserves: Future policy benefits on the Condensed Consolidated Balance Sheets.
The determination of Future policy benefits reserves requires management to make estimates and assumptions about expected policyholder experience over the remaining life of the policy. Since policies may be in force for several decades, these assumptions are subject to significant estimation risk. As a result of this variability, the Company’s future policy benefits reserves may be subject to material increases if actual experience develops adversely to the Company’s expectations.
Annually in the third quarter, actuarial analysis is performed on policyholder morbidity, persistency, premium rate actions and expense experience. This analysis, combined with judgment, informs the setting of updated cash flow assumptions used to estimate the LFPB. Actuarial analysis includes predictive modeling, actual to expected experience comparisons and trend analysis. Applicable industry research is also considered.
The cash flow assumption updates for the third quarter of 2025 resulted in a $
7
million pretax increase in the LFPB. Included in the assumption updates were unfavorable incidence, claim closure and cost of care inflation impacts offset by favorable premium rate actions.
The cash flow assumption updates for the third quarter 2024 resulted in a $
15
million pretax increase to the LFPB. Included in the assumption updates was a favorable impact from outperformance on premium rate assumptions and an unfavorable impact from higher cost of care inflation.
See Note A to the Consolidated Financial Statements within CNAF's Annual Report on Form 10-K for the year ended December 31, 2024 for further information on the long-term care reserving process.
29
Table of Contents
The following table summarizes balances and changes in the LFPB.
(In millions)
2025
2024
Present value of future net premiums
Balance, January 1
$
3,425
$
3,710
Effect of changes in discount rate
(
7
)
(
125
)
Balance, January 1, at original locked in discount rate
3,418
3,585
Effect of changes in cash flow assumptions
(1)
114
111
Effect of actual variances from expected experience
(1)
(
2
)
(
40
)
Adjusted balance, January 1
3,530
3,656
Interest accrual
133
139
Net premiums: earned during period
(
306
)
(
317
)
Balance, end of period at original locked in discount rate
3,357
3,478
Effect of changes in discount rate
83
147
Balance, September 30
$
3,440
$
3,625
Present value of future benefits & expenses
Balance, January 1
$
16,583
$
17,669
Effect of changes in discount rate
440
(
578
)
Balance, January 1, at original locked in discount rate
17,023
17,091
Effect of changes in cash flow assumptions
(1)
121
126
Effect of actual variances from expected experience
(1)
50
33
Adjusted balance, January 1
17,194
17,250
Interest accrual
688
693
Benefit & expense payments
(
870
)
(
883
)
Balance, end of period at original locked in discount rate
17,012
17,060
Effect of changes in discount rate
(
26
)
612
Balance, September 30
$
16,986
$
17,672
Net LFPB
$
13,546
$
14,047
(1) As of September 30, 2025 and 2024 the re-measurement gain (loss) of $(
59
) million and $(
88
) million presented parenthetically on the Condensed Consolidated Statement of Operations is comprised of the effect of changes in cash flow assumptions and the effect of actual variances from expected experience.
30
Table of Contents
The following table presents earned premiums and interest accretion associated with the Company’s long-term care business recognized on the Condensed Consolidated Statement of Operations.
Periods ended September 30
Three Months
Nine Months
(In millions)
2025
2024
2025
2024
Earned premiums
$
106
$
110
$
318
$
329
Interest accretion
185
185
555
554
The following table presents undiscounted expected future benefit and expense payments, and undiscounted expected future gross premiums.
As of September 30
(In millions)
2025
2024
Expected future benefit and expense payments
$
31,582
$
32,009
Expected future gross premiums
5,048
5,305
Discounted expected future gross premiums at the upper-medium grade fixed income instrument yield discount rate were $
3,580
million and $
3,792
million as of September 30, 2025 and 2024.
The weighted average effective duration of the LFPB calculated using the original locked in discount rate was
11
years as of September 30, 2025 and 2024.
The weighted average interest rates in the table below are calculated based on the rate used to discount all future cash flows.
As of September 30
As of December 31
2025
2024
2024
Original locked in discount rate
5.16
%
5.20
%
5.20
%
Upper-medium grade fixed income instrument discount rate
5.24
4.90
5.51
For the three and nine months ended September 30, 2025, immediate charges to net income resulting from adverse development in certain cohorts where the Net Premium Ratio (NPR) exceeded 100% were $
65
million and $
93
million. For the three and nine months ended September 30, 2024, immediate charges to net income resulting from adverse development in certain cohorts where the NPR exceeded 100% were $
84
million and $
128
million.
For the three and nine months ended September 30, 2025, the portion of losses recognized in a prior period due to NPR exceeding 100% for certain cohorts which, due to favorable development, was reversed through net income were $
43
million and $
54
million. For the three and nine months ended September 30, 2024, the portion of losses recognized in a prior period due to NPR exceeding 100% for certain cohorts which, due to favorable development, was reversed through net income were $
20
million and $
28
million.
31
Table of Contents
Note G
.
Legal Proceedings, Contingencies and Guarantees
The Company is a party to various claims and litigation incidental to its business, which, based on the facts and circumstances currently known, are not material to the Company's results of operations or financial position.
Guarantees
The Company has provided guarantees, if the primary obligor fails to perform, to holders of structured settlement annuities issued by a previously owned subsidiary. As of September 30, 2025, the potential amount of future payments the Company could be required to pay under these guarantees was approximately $
1.9
billion, which will be paid over the lifetime of the annuitants. The Company does not believe any payment is likely under these guarantees, as the Company is the beneficiary of a trust that must be maintained at a level that approximates the discounted reserves for these annuities.
32
Table of Contents
Note H.
Benefit Plans
The components of net periodic pension cost (benefit) are presented in the following table.
Periods ended September 30
Three Months
Nine Months
(In millions)
2025
2024
2025
2024
Net periodic pension cost (benefit)
Interest cost on projected benefit obligation
$
9
$
21
$
27
$
65
Expected return on plan assets
(
14
)
(
29
)
(
41
)
(
87
)
Amortization of net actuarial loss (gain)
2
7
6
21
Pension settlement transaction loss
—
4
—
4
Total net periodic pension cost (benefit)
$
(
3
)
$
3
$
(
8
)
$
3
The following table indicates the line items in which the non-service cost (benefit) is presented in the Condensed Consolidated Statements of Operations.
Periods ended September 30
Three Months
Nine Months
(In millions)
2025
2024
2025
2024
Non-Service Cost (Benefit):
Insurance claims and policyholder's benefits
$
(
1
)
$
1
$
(
2
)
$
1
Other operating expenses
(
2
)
2
(
6
)
2
Total net periodic pension cost (benefit)
$
(
3
)
$
3
$
(
8
)
$
3
In 2024, a subsidiary of CNAF, as a sponsor of the CNA Canada Employee Pension Plan (the Canada Plan), purchased a nonparticipating single premium group annuity contract, under which the defined benefit pension obligation of the Canada Plan was transferred in full to an insurance company counterparty. As a result of the transaction, the Company recognized a one-time, non-cash, pretax pension settlement charge of $
4
million ($
3
million after-tax).
33
Table of Contents
Note I.
Accumulated Other Comprehensive Income (Loss) by Component
The tables below display the changes in Accumulated other comprehensive income (loss) by component.
(In millions)
Net unrealized gains (losses) on investments with an allowance for credit losses
Net unrealized gains (losses) on other investments
Pension and postretirement benefits
Cumulative impact of changes in discount rates used to measure long duration contracts
Cumulative foreign currency translation adjustment
Total
Balance as of July 1, 2025
$
(
15
)
$
(
1,521
)
$
(
188
)
$
236
$
(
98
)
$
(
1,586
)
Other comprehensive income (loss) before reclassifications
(
1
)
554
—
(
150
)
(
38
)
365
Amounts reclassified from accumulated other comprehensive income (loss) net of tax (expense) benefit of $
2
, $
—
, $
—
, $
—
, $
—
and $
2
(
4
)
(
4
)
(
2
)
—
—
(
10
)
Other comprehensive income (loss) net of tax (expense) benefit of $(
1
), $(
148
), $
—
, $
40
, $
—
and $(
109
)
3
558
2
(
150
)
(
38
)
375
Balance as of September 30, 2025
$
(
12
)
$
(
963
)
$
(
186
)
$
86
$
(
136
)
$
(
1,211
)
(In millions)
Net unrealized gains (losses) on investments with an allowance for credit losses
Net unrealized gains (losses) on other investments
Pension and postretirement benefits
Cumulative impact of changes in discount rates used to measure long duration contracts
Cumulative foreign currency translation adjustment
Total
Balance as of July 1, 2024
$
(
10
)
$
(
2,074
)
$
(
513
)
$
255
$
(
205
)
$
(
2,547
)
Other comprehensive income (loss) before reclassifications
(
9
)
1,254
—
(
623
)
63
685
Amounts reclassified from accumulated other comprehensive income (loss) net of tax (expense) benefit of $
2
, $
3
, $
3
, $
—
, $
—
and $
8
(
6
)
(
11
)
(
8
)
—
—
(
25
)
Other comprehensive income (loss) net of tax (expense) benefit of $
1
, $(
340
), $(
3
), $
165
, $
—
and $(
177
)
(
3
)
1,265
8
(
623
)
63
710
Balance as of September 30, 2024
$
(
13
)
$
(
809
)
$
(
505
)
$
(
368
)
$
(
142
)
$
(
1,837
)
34
Table of Contents
(In millions)
Net unrealized gains (losses) on investments with an allowance for credit losses
Net unrealized gains (losses) on other investments
Pension and postretirement benefits
Cumulative impact of changes in discount rates used to measure long duration contracts
Cumulative foreign currency translation adjustment
Total
Balance as of January 1, 2025
$
(
13
)
$
(
1,876
)
$
(
191
)
$
353
$
(
264
)
$
(
1,991
)
Other comprehensive income (loss) before reclassifications
(
11
)
873
—
(
267
)
128
723
Amounts reclassified from accumulated other comprehensive income (loss) net of tax (expense) benefit of $
4
, $
11
, $
1
, $
—
, $
—
and $
16
(
12
)
(
40
)
(
5
)
—
—
(
57
)
Other comprehensive income (loss) net of tax (expense) benefit of $
—
, $(
244
), $(
1
), $
71
, $
—
and $(
174
)
1
913
5
(
267
)
128
780
Balance as of September 30, 2025
$
(
12
)
$
(
963
)
$
(
186
)
$
86
$
(
136
)
$
(
1,211
)
(In millions)
Net unrealized gains (losses) on investments with an allowance for credit losses
Net unrealized gains (losses) on other investments
Pension and postretirement benefits
Cumulative impact of changes in discount rates used to measure long duration contracts
Cumulative foreign currency translation adjustment
Total
Balance as of January 1, 2024
$
(
12
)
$
(
1,613
)
$
(
525
)
$
(
359
)
$
(
163
)
$
(
2,672
)
Other comprehensive income (loss) before reclassifications
(
14
)
765
—
(
9
)
21
763
Amounts reclassified from accumulated other comprehensive income (loss) net of tax (expense) benefit of $
4
, $
10
, $
5
, $
—
, $
—
and $
19
(
13
)
(
39
)
(
20
)
—
—
(
72
)
Other comprehensive income (loss) net of tax (expense) benefit of $
—
, $(
216
), $(
5
), $
2
, $
—
and $(
219
)
(
1
)
804
20
(
9
)
21
835
Balance as of September 30, 2024
$
(
13
)
$
(
809
)
$
(
505
)
$
(
368
)
$
(
142
)
$
(
1,837
)
Amounts reclassified from Accumulated other comprehensive income (loss) shown above are reported in Net income (loss) as follows:
Component of AOCI
Condensed Consolidated Statements of Operations Line Item Affected by Reclassifications
Net unrealized gains (losses) on investments with an allowance for credit losses and Net unrealized gains (losses) on other investments
Net investment gains (losses)
Pension and postretirement benefits
Other operating expenses and Insurance claims and policyholders' benefits
35
Table of Contents
Note J.
Business Segments
The Company's property and casualty commercial insurance operations are managed and reported in
three
business segments: Specialty, Commercial and International. These
three
segments are collectively referred to as Property & Casualty Operations. The Company's operations outside of Property & Casualty Operations are managed and reported in
two
segments: Life & Group and Corporate & Other.
The accounting policies of the segments are the same as those described in Note A to the Consolidated Financial Statements within CNAF's Annual Report on Form 10-K for the year ended December 31, 2024. The Company manages most of its assets on a legal entity basis, while segment operations are generally conducted across legal entities. As such, only Insurance and Reinsurance receivables, Insurance reserves, Deferred acquisition costs, Goodwill and Deferred non-insurance warranty acquisition expense and revenue are readily identifiable for individual segments. Distinct investment portfolios are not maintained for every individual segment; accordingly, allocation of assets to each segment is not performed. Therefore, a significant portion of Net investment income is allocated primarily based on each segment's net carried insurance reserves, as adjusted. All significant intersegment income and expense have been eliminated. Income taxes have been allocated on the basis of the taxable income of the segments.
In the following tables, certain financial measures are presented to provide information used by management to monitor the Company's operating performance. Management utilizes these financial measures to monitor the Company's insurance operations and investment portfolio.
The performance of the Company's insurance operations is monitored by management through core income (loss). The Company's Chief Operating Decision Maker (CODM) is the Chief Executive Officer. For all segments, the CODM uses a multi-year trend of core income (loss) to assess the segments' operating performance and make decisions regarding the allocation of resources to each segment.
Core income (loss) is calculated by excluding from net income (loss) the after-tax effects of net investment gains or losses and gains or losses resulting from pension settlement transactions. Net investment gains or losses are excluded from the calculation of core income (loss) because they are generally driven by economic factors that are not necessarily reflective of the Company's primary operations. The calculation of core income (loss) excludes gains or losses resulting from pension settlement transactions as they result from decisions regarding the Company's defined benefit pension plans which are unrelated to the Company's primary operations.
The Company's investment portfolio is monitored by management through analysis of various factors including unrealized gains and losses on securities, portfolio duration and exposure to market and credit risk.
36
Table of Contents
The Company's results of operations and selected balance sheet items by segment are presented in the following tables.
Three months ended September 30, 2025
Specialty
Commercial
International
Life &
Group
Corporate
& Other
(In millions)
Eliminations
Total
Operating revenues
Net earned premiums
$
881
$
1,453
$
344
$
106
$
—
$
(
1
)
$
2,783
Net investment income
162
192
42
226
16
—
638
Non-insurance warranty revenue
393
—
—
—
—
—
393
Other revenues
1
8
—
—
2
(
1
)
10
Total operating revenues
1,437
1,653
386
332
18
(
2
)
3,824
Claims, benefits and expenses
Net incurred claims and benefits
534
960
203
336
(
10
)
—
2,023
Policyholders’ dividends
2
7
—
—
—
—
9
Amortization of deferred acquisition costs
197
215
71
—
—
—
483
Non-insurance warranty expense
377
—
—
—
—
—
377
Insurance related administrative expenses
88
165
42
29
1
(
1
)
324
Interest expense
—
—
—
—
36
—
36
Other segment items
(1)
16
11
(
1
)
—
27
(
1
)
52
Total claims, benefits and expenses
1,214
1,358
315
365
54
(
2
)
3,304
Income tax (expense) benefit on core income (loss)
(
47
)
(
62
)
(
24
)
11
11
—
(
111
)
Core income (loss)
$
176
$
233
$
47
$
(
22
)
$
(
25
)
$
—
$
409
Net investment gains (losses)
(
7
)
Income tax (expense) benefit on net investment gains (losses)
1
Net investment gains (losses), after tax
(
6
)
Net income (loss)
$
403
(1) Other segment items for the Company's property and casualty insurance segments reflects expenses not directly related to the Company's insurance operations, including certain expenses related to the Company's non-insurance warranty business within Specialty, claims services offerings within Commercial and foreign currency transaction gains and losses within International. Other segment items for the Corporate & Other segment reflects certain corporate expenses not attributable to the Company's ongoing property and casualty insurance operations.
37
Table of Contents
Three months ended September 30, 2024
Specialty
Commercial
International
Life &
Group
Corporate
& Other
(In millions)
Eliminations
Total
Operating revenues
Net earned premiums
$
848
$
1,325
$
311
$
110
$
—
$
(
1
)
$
2,593
Net investment income
157
183
32
240
14
—
626
Non-insurance warranty revenue
401
—
—
—
—
—
401
Other revenues
1
5
—
—
3
(
1
)
8
Total operating revenues
1,407
1,513
343
350
17
(
2
)
3,628
Claims, benefits and expenses
Net incurred claims and benefits
509
954
195
336
16
—
2,010
Policyholders’ dividends
2
7
—
—
—
—
9
Amortization of deferred acquisition costs
188
209
60
—
—
—
457
Non-insurance warranty expense
387
—
—
—
—
—
387
Insurance related administrative expenses
90
158
44
30
—
(
1
)
321
Interest expense
—
—
—
—
32
—
32
Other segment items
(1)
13
8
(
8
)
1
24
(
1
)
37
Total claims, benefits and expenses
(2)
1,189
1,336
291
367
72
(
2
)
3,253
Income tax (expense) benefit on core income (loss)
(
47
)
(
38
)
(
16
)
8
11
—
(
82
)
Core income (loss)
$
171
$
139
$
36
$
(
9
)
$
(
44
)
$
—
$
293
Net investment gains (losses)
(
10
)
Income tax (expense) benefit on net investment gains (losses)
3
Net investment gains (losses), after tax
(
7
)
Pension settlement transaction gains (losses)
(
4
)
Income tax (expense) benefit on pension settlement transaction gains (losses)
1
Pension settlement transaction gains (losses), after tax
(
3
)
Net income (loss)
$
283
(1) Other segment items for the Company's property and casualty insurance segments reflects expenses not directly related to the Company's insurance operations, including certain expenses related to the Company's non-insurance warranty business within Specialty, claims services offerings within Commercial and foreign currency transaction gains and losses within International. Other segment items for the Corporate & Other segment reflects certain corporate expenses not attributable to the Company's ongoing property and casualty insurance operations.
(2) Excludes the impact of pension settlement transaction gains (losses). See Note H to the Condensed Consolidated Financial Statements for additional information.
38
Table of Contents
Nine months ended September 30, 2025
Specialty
Commercial
International
Life &
Group
Corporate
& Other
(In millions)
Eliminations
Total
Operating revenues
Net earned premiums
$
2,573
$
4,235
$
978
$
318
$
—
$
(
1
)
$
8,103
Net investment income
483
575
114
687
45
—
1,904
Non-insurance warranty revenue
1,188
—
—
—
—
—
1,188
Other revenues
1
26
—
—
8
(
7
)
28
Total operating revenues
4,245
4,836
1,092
1,005
53
(
8
)
11,223
Claims, benefits and expenses
Net incurred claims and benefits
1,562
2,907
590
949
107
—
6,115
Policyholders’ dividends
7
22
—
—
—
—
29
Amortization of deferred acquisition costs
581
645
197
—
—
—
1,423
Non-insurance warranty expense
1,146
—
—
—
—
—
1,146
Insurance related administrative expenses
268
498
125
90
2
(
1
)
982
Interest expense
—
—
—
—
99
—
99
Other segment items
(1)
41
36
(
12
)
1
66
(
7
)
125
Total claims, benefits and expenses
3,605
4,108
900
1,040
274
(
8
)
9,919
Income tax (expense) benefit on core income (loss)
(
137
)
(
153
)
(
55
)
20
46
—
(
279
)
Core income (loss)
$
503
$
575
$
137
$
(
15
)
$
(
175
)
$
—
$
1,025
Net investment gains (losses)
(
62
)
Income tax (expense) benefit on net investment gains (losses)
13
Net investment gains (losses), after tax
(
49
)
Net income (loss)
$
976
(1) Other segment items for the Company's property and casualty insurance segments reflects expenses not directly related to the Company's insurance operations, including certain expenses related to the Company's non-insurance warranty business within Specialty, claims services offerings within Commercial and foreign currency transaction gains and losses within International. Other segment items for the Corporate & Other segment reflects certain corporate expenses not attributable to the Company's ongoing property and casualty insurance operations.
39
Table of Contents
September 30, 2025
Specialty
Commercial
International
Life &
Group
Corporate
& Other
(In millions)
Eliminations
Total
Reinsurance receivables
$
1,803
$
1,786
$
559
$
77
$
2,242
$
—
$
6,467
Insurance receivables
1,008
2,277
406
1
1
—
3,693
Deferred acquisition costs
447
395
143
—
—
—
985
Goodwill
117
—
31
—
—
—
148
Deferred non-insurance warranty acquisition expense
3,340
—
—
—
—
—
3,340
Insurance reserves
Claim and claim adjustment expenses
7,769
12,153
3,315
615
2,673
—
26,525
Unearned premiums
3,295
3,392
796
95
—
—
7,578
Future policy benefits
—
—
—
13,546
—
—
13,546
Deferred non-insurance warranty revenue
4,294
—
—
—
—
—
4,294
40
Table of Contents
Nine months ended September 30, 2024
Specialty
Commercial
International
Life &
Group
Corporate
& Other
(In millions)
Eliminations
Total
Operating revenues
Net earned premiums
$
2,493
$
3,774
$
937
$
329
$
—
$
(
1
)
$
7,532
Net investment income
461
534
95
710
53
—
1,853
Non-insurance warranty revenue
1,212
—
—
—
—
—
1,212
Other revenues
1
23
—
—
9
(
7
)
26
Total operating revenues
4,167
4,331
1,032
1,039
62
(
8
)
10,623
Claims, benefits and expenses
Net incurred claims and benefits
1,478
2,628
568
973
35
—
5,682
Policyholders’ dividends
7
19
—
—
—
—
26
Amortization of deferred acquisition costs
546
608
182
—
—
—
1,336
Non-insurance warranty expense
1,169
—
—
—
—
—
1,169
Insurance related administrative expenses
267
454
129
88
—
(
1
)
937
Interest expense
—
—
—
—
101
—
101
Other segment items
(1)
41
33
(
5
)
2
72
(
7
)
136
Total claims, benefits and expenses
(2)
3,508
3,742
874
1,063
208
(
8
)
9,387
Income tax (expense) benefit on core income (loss)
(
142
)
(
125
)
(
41
)
19
27
—
(
262
)
Core income (loss)
$
517
$
464
$
117
$
(
5
)
$
(
119
)
$
—
$
974
Net investment gains (losses)
(
42
)
Income tax (expense) benefit on net investment gains (losses)
9
Net investment gains (losses), after tax
(
33
)
Pension settlement transaction gains (losses)
(
4
)
Income tax (expense) benefit on pension settlement transaction gains (losses)
1
Pension settlement transaction gains (losses), after tax
(
3
)
Net income (loss)
$
938
(1) Other segment items for the Company's property and casualty insurance segments reflects expenses not directly related to the Company's insurance operations, including certain expenses related to the Company's non-insurance warranty business within Specialty, claims services offerings within Commercial and foreign currency transaction gains and losses within International. Other segment items for the Corporate & Other segment reflects certain corporate expenses not attributable to the Company's ongoing property and casualty insurance operations.
(2) Excludes the impact of pension settlement transaction gains (losses). See Note H to the Condensed Consolidated Financial Statements for additional information.
41
Table of Contents
December 31, 2024
Specialty
Commercial
International
Life &
Group
Corporate
& Other
(In millions)
Eliminations
Total
Reinsurance receivables
$
1,405
$
1,710
$
539
$
82
$
2,336
$
—
$
6,072
Insurance receivables
1,062
2,219
410
4
2
—
3,697
Deferred acquisition costs
427
405
127
—
—
—
959
Goodwill
117
—
28
—
—
—
145
Deferred non-insurance warranty acquisition expense
3,525
—
—
—
—
—
3,525
Insurance reserves
Claim and claim adjustment expenses
7,426
11,336
2,920
622
2,672
—
24,976
Unearned premiums
3,275
3,252
727
92
—
—
7,346
Future policy benefits
—
—
—
13,158
—
—
13,158
Deferred non-insurance warranty revenue
4,530
—
—
—
—
—
4,530
42
Table of Contents
The following table presents further detail of significant segment expenses included within Net incurred claims and benefits for the Property & Casualty segments.
Periods ended September 30
Three Months
Nine Months
(In millions)
2025
2024
2025
2024
Specialty
Non-catastrophe net incurred claim and claim adjustment expenses related to current year
$
534
$
509
$
1,552
$
1,486
Catastrophe losses
—
—
—
—
(Favorable) unfavorable development
(1)
—
—
10
(
8
)
Commercial
Non-catastrophe net incurred claim and claim adjustment expenses related to current year
$
921
$
829
$
2,674
$
2,350
Catastrophe losses
39
127
182
285
(Favorable) unfavorable development
(1)
(
1
)
(
3
)
46
(
11
)
International
Non-catastrophe net incurred claim and claim adjustment expenses related to current year
$
201
$
181
$
572
$
545
Catastrophe losses
2
16
18
28
(Favorable) unfavorable development
(1)
—
(
2
)
—
(
5
)
(1) (Favorable) unfavorable development does not include the effects of interest accretion and change in allowance for uncollectible reinsurance.
The following table presents operating revenues by line of business for each reportable segment.
Periods ended September 30
Three Months
Nine Months
(In millions)
2025
2024
2025
2024
Specialty
Management & Professional Liability
$
773
$
753
$
2,297
$
2,215
Surety
225
202
618
580
Warranty & Alternative Risks
439
452
1,330
1,372
Specialty revenues
1,437
1,407
4,245
4,167
Commercial
Middle Market
483
448
1,430
1,307
Construction
535
521
1,562
1,459
Small Business
160
161
477
472
Other Commercial
475
383
1,367
1,093
Commercial revenues
1,653
1,513
4,836
4,331
International
Canada
114
99
312
296
Europe
165
150
465
440
Hardy
107
94
315
296
International revenues
386
343
1,092
1,032
Life & Group revenues
332
350
1,005
1,039
Corporate & Other revenues
18
17
53
62
Eliminations
(
2
)
(
2
)
(
8
)
(
8
)
Total operating revenues
3,824
3,628
11,223
10,623
Net investment gains (losses)
(
7
)
(
10
)
(
62
)
(
42
)
Total revenues
$
3,817
$
3,618
$
11,161
$
10,581
43
Table of Contents
Note K.
Non-Insurance Revenues from Contracts with Customers
The Company had a deferred non-insurance warranty revenue balance of $
4.3
billion and $
4.5
billion reported under Liabilities as of September 30, 2025 and December 31, 2024. For the three and nine months ended September 30, 2025, the Company recognized $
0.4
billion and $
1.1
billion of revenues that were included in the deferred revenue balance as of January 1, 2025. For the three and nine months ended September 30, 2024, the Company recognized $
0.3
billion and $
1.1
billion of revenues that were included in the deferred revenue balance as of January 1, 2024. For the three and nine months ended September 30, 2025 and 2024, non-insurance warranty revenue recognized from performance obligations related to prior periods due to a change in estimate was not material. The Company expects to recognize approximately $
0.4
billion of the deferred revenue in the remainder of 2025, $
1.2
billion in 2026, $
1.0
billion in 2027 and $
1.7
billion thereafter.
44
Table of Contents
Item 2. Management's Discussion and Analysis (MD&A) of Financial Conditions and Results of Operations
OVERVIEW
The following discussion highlights significant factors affecting the Company. References to “we,” “our,” “us” or like terms refer to the business of CNA.
The following discussion should be read in conjunction with the Condensed Consolidated Financial Statements included under Part I, Item 1 of this Form 10-Q, and Item 1A Risk Factors and Item 7 Management's Discussion and Analysis of Financial Condition and Results of Operations, which are included in our Annual Report on Form 10-K filed with the Securities and Exchange Commission for the year ended December 31, 2024.
We utilize the core income (loss) financial measure to monitor our operations. Core income (loss) is calculated by excluding from net income (loss) the after-tax effects of net investment gains or losses and gains or losses resulting from pension settlement transactions. Net investment gains or losses are excluded from the calculation of core income (loss) because they are generally driven by economic factors that are not necessarily reflective of our primary operations. The calculation of core income (loss) excludes gains or losses resulting from pension settlement transactions as they result from decisions regarding our defined benefit pension plans which are unrelated to our primary operations. Presentation of consolidated core income (loss) is deemed to be a non-GAAP financial measure and management believes some investors may find this measure useful to evaluate our primary operations. See further discussion regarding how we manage our business in Note J to the Condensed Consolidated Financial Statements included under Part I, Item 1. For reconciliations of non-GAAP measures to the most comparable GAAP measures and other information, please refer herein and/or to our most recent Annual Report on Form 10-K on file with the Securities and Exchange Commission.
In evaluating the results of our Specialty, Commercial and International segments, we utilize the loss ratio, the underlying loss ratio, the expense ratio, the dividend ratio, the combined ratio and the underlying combined ratio. These ratios are calculated using GAAP financial results. The loss ratio is the percentage of net incurred claim and claim adjustment expenses to net earned premiums. The underlying loss ratio excludes the impact of catastrophe losses and development-related items from the loss ratio. Development-related items represents net prior year loss reserve and premium development, and includes the effects of interest accretion and change in allowance for uncollectible reinsurance. The expense ratio is the percentage of insurance underwriting and acquisition expenses, including the amortization of deferred acquisition costs, to net earned premiums. The dividend ratio is the ratio of policyholders' dividends incurred to net earned premiums. The combined ratio is the sum of the loss ratio, the expense ratio and the dividend ratio. The underlying combined ratio is the sum of the underlying loss ratio, the expense ratio and the dividend ratio. The underlying loss ratio and the underlying combined ratio are deemed to be non-GAAP financial measures, and management believes some investors may find these ratios useful to evaluate our underwriting performance since they remove the impact of catastrophe losses which are unpredictable as to timing and amount, and development-related items as they are not indicative of our current year underwriting performance.
Changes in estimates of claim and claim adjustment expense reserves, net of reinsurance, for prior years are defined as net prior year loss reserve development within this MD&A. These changes can be favorable or unfavorable. Net prior year loss reserve development does not include the effect of any related acquisition expenses. Further information on our reserves is provided in Note E and Note F to the Condensed Consolidated Financial Statements included under Part I, Item 1.
In addition, we also utilize renewal premium change, rate, retention and new business in evaluating operating trends. Renewal premium change represents the estimated change in average premium on policies that renew, including rate and exposure changes. Rate represents the average change in price on policies that renew excluding exposure change. Exposure represents the measure of risk used in the pricing of the insurance product. The change in exposure represents the change in premium dollars on policies that renew as a result of the change in risk of the policy. Retention represents the percentage of premium dollars renewed, excluding rate and exposure changes, in comparison to the expiring premium dollars from policies available to renew. New business represents premiums from policies written with new customers and additional policies written
45
Table of Contents
with existing customers. Gross written premiums, excluding third-party captives, excludes business which is ceded to third-party captives, including business related to large warranty programs.
We use underwriting gain (loss) and underlying underwriting gain (loss), calculated using GAAP financial results, to monitor our insurance operations. Underwriting gain (loss) is deemed to be a non-GAAP financial measure and is calculated pretax as net earned premiums less total insurance expenses, which includes insurance claims and policyholders' benefits, amortization of deferred acquisition costs and insurance related administrative expenses. Net income (loss) is the most directly comparable GAAP measure. Management believes some investors may find this measure useful to evaluate the profitability, before tax, derived from our underwriting activities, which are managed separately from our investing activities. Underlying underwriting gain (loss) is also deemed to be a non-GAAP financial measure, and represents pretax underwriting gain (loss) excluding catastrophe losses and development-related items. Management believes some investors may find this measure useful to evaluate the profitability, before tax, derived from our underwriting activities, excluding the impact of catastrophe losses, which are unpredictable as to timing and amount, and development-related items as they are not indicative of our current year underwriting performance.
The following tables present reconciliations of net income to core income, underwriting gain and underlying underwriting gain for our Property & Casualty Operations:
Three months ended September 30, 2025
Specialty
Commercial
International
Property & Casualty
(In millions)
Net income
$
173
$
229
$
44
$
446
Net investment losses, after tax
3
4
3
10
Core income
$
176
$
233
$
47
$
456
Less:
Net investment income
162
192
42
396
Non-insurance warranty revenue (expense)
16
—
—
16
Other revenue (expense), including interest expense
(15)
(3)
1
(17)
Income tax expense on core income
(47)
(62)
(24)
(133)
Underwriting gain
60
106
28
194
Effect of catastrophe losses
—
39
2
41
Effect of development-related items
—
—
—
—
Underlying underwriting gain
$
60
$
145
$
30
$
235
Three months ended September 30, 2024
Specialty
Commercial
International
Property & Casualty
(In millions)
Net income
$
167
$
132
$
34
$
333
Net investment losses, after tax
4
7
2
13
Core income
$
171
$
139
$
36
$
346
Less:
Net investment income
157
183
32
372
Non-insurance warranty revenue (expense)
14
—
—
14
Other revenue (expense), including interest expense
(12)
(3)
8
(7)
Income tax expense on core income
(47)
(38)
(16)
(101)
Underwriting gain (loss)
59
(3)
12
68
Effect of catastrophe losses
—
127
16
143
Effect of favorable development-related items
—
—
(2)
(2)
Underlying underwriting gain
$
59
$
124
$
26
$
209
46
Table of Contents
Nine months ended September 30, 2025
Specialty
Commercial
International
Property & Casualty
(In millions)
Net income
$
487
$
552
$
135
$
1,174
Net investment losses, after tax
16
23
2
41
Core income
$
503
$
575
$
137
$
1,215
Less:
Net investment income
483
575
114
1,172
Non-insurance warranty revenue (expense)
42
—
—
42
Other revenue (expense), including interest expense
(40)
(10)
12
(38)
Income tax expense on core income
(137)
(153)
(55)
(345)
Underwriting gain
155
163
66
384
Effect of catastrophe losses
—
182
18
200
Effect of unfavorable development-related items
10
54
—
64
Underlying underwriting gain
$
165
$
399
$
84
$
648
Nine months ended September 30, 2024
Specialty
Commercial
International
Property & Casualty
(In millions)
Net income
$
498
$
436
$
116
$
1,050
Net investment losses, after tax
19
28
1
48
Core income
$
517
$
464
$
117
$
1,098
Less:
Net investment income
461
534
95
1,090
Non-insurance warranty revenue (expense)
43
—
—
43
Other revenue (expense), including interest expense
(40)
(10)
5
(45)
Income tax expense on core income
(142)
(125)
(41)
(308)
Underwriting gain
195
65
58
318
Effect of catastrophe losses
—
285
28
313
Effect of favorable development-related items
(8)
—
(5)
(13)
Underlying underwriting gain
$
187
$
350
$
81
$
618
The following table presents a reconciliation of net (loss) income to core loss for our Life & Group segment:
Periods ended September 30
Three Months
Nine Months
(In millions)
2025
2024
2025
2024
Net (loss) income
$
(17)
$
(3)
$
(22)
$
11
Net investment (gains) losses, after tax
(5)
(6)
7
(16)
Core loss
$
(22)
$
(9)
$
(15)
$
(5)
The following table present a reconciliation of net loss to core loss for our Corporate & Other segment:
Periods ended September 30
Three Months
Nine Months
(In millions)
2025
2024
2025
2024
Net loss
$
(26)
$
(47)
$
(176)
$
(123)
Net investment losses, after tax
1
—
1
1
Net pension settlement losses, after tax
—
3
—
3
Core loss
$
(25)
$
(44)
$
(175)
$
(119)
47
Table of Contents
CRITICAL ACCOUNTING ESTIMATES
The preparation of the Condensed Consolidated Financial Statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the Condensed Consolidated Financial Statements and the amount of revenues and expenses reported during the period. Actual results may differ from those estimates.
Our Condensed Consolidated Financial Statements and accompanying notes have been prepared in accordance with GAAP applied on a consistent basis. We continually evaluate the accounting policies and estimates used to prepare the Condensed Consolidated Financial Statements. In general, our estimates are based on historical experience, evaluation of current trends, information from third-party professionals and various other assumptions that are believed to be reasonable under the known facts and circumstances.
The accounting estimates set forth below are considered by us to be critical to an understanding of our Condensed Consolidated Financial Statements as their application places the most significant demands on our judgment:
•
Insurance Reserves
•
Long-Term Care Reserves
•
Reinsurance and Insurance Receivables
•
Valuation of Investments and Impairment of Securities
Due to the inherent uncertainties involved with these types of judgments, actual results could differ significantly from our estimates and may have a material adverse impact on our results of operations, financial condition, equity, business, and insurer financial strength and corporate debt ratings. See the Critical Accounting Estimates section of our Management's Discussion and Analysis of Financial Condition and Results of Operations included under Item 7 of our Annual Report on Form 10-K for the year ended December 31, 2024 for further information.
48
Table of Contents
CONSOLIDATED OPERATIONS
Results of Operations
The following table includes the consolidated results of our operations including our financial measure, core income (loss). For more detailed components of our business operations and a discussion of the core income (loss) financial measure, see the Segment Results section within this MD&A. For further discussion of Net investment income and Net investment gains or losses, see the Investments section of this MD&A.
Periods ended September 30
Three Months
Nine Months
(In millions)
2025
2024
2025
2024
Operating Revenues
Net earned premiums
$
2,783
$
2,593
$
8,103
$
7,532
Net investment income
638
626
1,904
1,853
Non-insurance warranty revenue
393
401
1,188
1,212
Other revenues
10
8
28
26
Total operating revenues
3,824
3,628
11,223
10,623
Claims, Benefits and Expenses
Net incurred claims and benefits (re-measurement loss of $36, $48, $59 and $88)
2,023
2,010
6,115
5,682
Policyholders' dividends
9
9
29
26
Amortization of deferred acquisition costs
483
457
1,423
1,336
Non-insurance warranty expense
377
387
1,146
1,169
Insurance related administrative expenses
324
321
982
937
Interest expense
36
32
99
101
Other expenses
52
37
125
136
Total claims, benefits and expenses
3,304
3,253
9,919
9,387
Income tax expense on core income
(111)
(82)
(279)
(262)
Core income
409
293
1,025
974
Net investment losses
(7)
(10)
(62)
(42)
Income tax benefit on net investment losses
1
3
13
9
Net investment losses, after tax
(6)
(7)
(49)
(33)
Pension settlement transaction losses
—
(4)
—
(4)
Income tax benefit on pension settlement transaction losses
—
1
—
1
Pension settlement transaction losses, after tax
—
(3)
—
(3)
Net income
$
403
$
283
$
976
$
938
Three Month Comparison
Core income increased $116 million for the three months ended September 30, 2025 as compared with the same period in 2024. Core income for our Property & Casualty Operations increased $110 million primarily driven by lower catastrophe losses, improved underlying underwriting results and higher net investment income. Core loss for our Life & Group segment increased $13 million, while core loss for our Corporate & Other segment improved $19 million.
Catastrophe losses were $41 million and $143 million for the three months ended September 30, 2025 and 2024 driven by severe weather related events. Catastrophe losses for three months ended September 30, 2024 included $55 million for Hurricane Helene. Favorable net prior year loss reserve development of $1 million was recorded for the three months ended September 30, 2025 compared to unfavorable net prior year loss reserve development of $17 million for the three months ended September 30, 2024 related to our Commercial, International and Corporate & Other segments. Further information on net prior year loss reserve development is in Note E to the Condensed Consolidated Financial Statements included under Part I, Item 1.
49
Table of Contents
Nine Month Comparison
Core income increased $51 million for the nine months ended September 30, 2025 as compared with the same period in 2024. Core income for our Property & Casualty Operations increased $117 million primarily driven by lower catastrophe losses, higher net investment income and improved underlying underwriting results, partially offset by unfavorable net prior year loss reserve development compared to favorable net prior year loss reserve development in the prior year period. Core loss for our Life & Group segment increased $10 million, while core loss for our Corporate & Other segment increased $56 million.
Catastrophe losses were $200 million and $313 million for the nine months ended September 30, 2025 and 2024 driven by severe weather related events. Catastrophe losses for the nine months ended September 30, 2024 included $55 million for Hurricane Helene. Unfavorable net prior year loss reserve development of $190 million and $33 million was recorded for the nine months ended September 30, 2025 and 2024 related to our Specialty, Commercial, International and Corporate & Other segments. Further information on net prior year loss reserve development is in Note E to the Condensed Consolidated Financial Statements included under Part I, Item 1.
50
Table of Contents
SEGMENT RESULTS
The following discusses the results of operations for our business segments. Our property and casualty commercial insurance operations are managed and reported in three business segments: Specialty, Commercial and International, which we refer to collectively as Property & Casualty Operations. Our operations outside of Property & Casualty Operations are managed and reported in two segments: Life & Group and Corporate & Other.
51
Table of Contents
Specialty
The following table details the results of operations for Specialty and provides the components to reconcile the combined ratio and loss ratio to the underlying combined ratio and underlying loss ratio.
Periods ended September 30
Three Months
Nine Months
(In millions, except ratios, rate, renewal premium change and retention)
2025
2024
2025
2024
Gross written premiums
$
1,700
$
1,743
$
5,064
$
5,153
Gross written premiums excluding third-party captives
1,009
982
2,952
2,846
Net written premiums
867
862
2,601
2,511
Net earned premiums
881
848
2,573
2,493
Underwriting gain
60
59
155
195
Net investment income
162
157
483
461
Core income
176
171
503
517
Other performance metrics:
Loss ratio
60.6
%
60.1
%
60.7
%
59.3
%
Expense ratio
32.5
32.7
33.0
32.5
Dividend ratio
0.2
0.2
0.3
0.3
Combined ratio
93.3
%
93.0
%
94.0
%
92.1
%
Less: Effect of catastrophe impacts
—
—
—
—
Less: Effect of unfavorable (favorable) development-related items
—
—
0.4
(0.3)
Underlying combined ratio
93.3
%
93.0
%
93.6
%
92.4
%
Underlying loss ratio
60.6
%
60.1
%
60.3
%
59.6
%
Rate
3
%
—
%
3
%
1
%
Renewal premium change
4
2
4
2
Retention
86
89
87
89
New business
$
131
$
129
$
365
$
341
Three Month Comparison
Gross written premiums, excluding third-party captives, for Specialty increased $27 million for the three months ended September 30, 2025 as compared with the same period in 2024 driven by favorable renewal premium change, inclusive of rate, partially offset by lower retention. Net written premiums for Specialty increased $5 million for the three months ended September 30, 2025 as compared with the same period in 2024. The increase in net earned premiums was consistent with the trend in net written premiums.
Core income increased $5 million for the three months ended September 30, 2025 as compared with the same period in 2024 due to higher net investment income.
The combined ratio of 93.3% increased 0.3 points for the three months ended September 30, 2025 as compared with the same period in 2024 due to a 0.5 point increase in the loss ratio partially offset by a 0.2 point improvement in the expense ratio. The increase in the loss ratio was due to an increase in the underlying loss ratio. There were no catastrophe losses for the three months ended September 30, 2025 and 2024. The improvement in the expense ratio was primarily driven by higher net earned premiums.
52
Table of Contents
Nine Month Comparison
Gross written premiums, excluding third-party captives, for Specialty increased $106 million for the nine months ended September 30, 2025 as compared with the same period in 2024 driven by favorable renewal premium change, inclusive of rate partially offset by lower retention. Net written premiums for Specialty increased $90 million for the nine months ended September 30, 2025 as compared with the same period in 2024. The increase in net earned premiums was consistent with the trend in net written premiums.
Core income decreased $14 million for the nine months ended September 30, 2025 as compared with the same period in 2024 primarily due to lower underlying underwriting results and unfavorable net prior year loss reserve development in the current year period compared with favorable net prior year loss reserve development in the prior year period, partially offset by higher net investment income.
The combined ratio of 94.0% increased 1.9 points for the nine months ended September 30, 2025 as compared with the same period in 2024 due to a 1.4 point increase in the loss ratio and a 0.5 point increase in the expense ratio. The increase in the loss ratio was due to unfavorable net prior year loss reserve development recorded in the current year period and an increase in the underlying loss ratio primarily driven by continued pricing pressure in management liability lines. The increase in the expense ratio was driven by higher employee related and acquisition costs partially offset by higher net earned premiums. There were no catastrophe losses for the nine months ended September 30, 2025 and 2024.
Unfavorable net prior year loss reserve development of $10 million was recorded for the nine months ended September 30, 2025 as compared with $8 million of favorable net prior year loss reserve development recorded for the nine months ended September 30, 2024. Further information on net prior year loss reserve development is in Note E to the Condensed Consolidated Financial Statements included under Part I Item 1.
The following table summarizes the gross and net carried reserves for Specialty.
(In millions)
September 30, 2025
December 31, 2024
Gross case reserves
$
2,078
$
2,023
Gross IBNR reserves
5,691
5,403
Total gross carried claim and claim adjustment expense reserves
$
7,769
$
7,426
Net case reserves
$
1,716
$
1,697
Net IBNR reserves
4,405
4,282
Total net carried claim and claim adjustment expense reserves
$
6,121
$
5,979
53
Table of Contents
Commercial
The following table details the results of operations for Commercial and provides the components to reconcile the combined ratio and loss ratio to the underlying combined ratio and underlying loss ratio.
Periods ended September 30
Three Months
Nine Months
(In millions, except ratios, rate, renewal premium change and retention)
2025
2024
2025
2024
Gross written premiums
$
1,569
$
1,547
$
5,487
$
5,160
Gross written premiums excluding third-party captives
1,559
1,538
5,301
5,022
Net written premiums
1,251
1,221
4,312
4,017
Net earned premiums
1,453
1,325
4,235
3,774
Underwriting gain (loss)
106
(3)
163
65
Net investment income
192
183
575
534
Core income
233
139
575
464
Other performance metrics:
Loss ratio
66.1
%
72.0
%
68.7
%
69.7
%
Expense ratio
26.1
27.7
26.9
28.1
Dividend ratio
0.5
0.5
0.5
0.5
Combined ratio
92.7
%
100.2
%
96.1
%
98.3
%
Less: Effect of catastrophe impacts
2.7
9.6
4.3
7.5
Less: Effect of (favorable) unfavorable development-related items
—
(0.1)
1.3
—
Underlying combined ratio
90.0
%
90.7
%
90.5
%
90.8
%
Underlying loss ratio
63.4
%
62.5
%
63.1
%
62.2
%
Rate
5
%
6
%
5
%
6
%
Renewal premium change
6
8
7
8
Retention
79
84
82
84
New business
$
324
$
345
$
1,114
$
1,117
Three Month Comparison
Gross written premiums for Commercial increased $22 million for the three months ended September 30, 2025 as compared with the same period in 2024 driven by favorable renewal premium change, inclusive of rate, partially offset by lower retention and new business. Net written premiums for Commercial increased $30 million for the three months ended September 30, 2025 as compared with the same period in 2024. The increase in net earned premiums was consistent with the trend in net written premiums.
Core income increased $94 million for the three months ended September 30, 2025 as compared with the same period in 2024, primarily driven by lower catastrophe losses, improved underlying underwriting results and higher net investment income.
The combined ratio of 92.7% improved 7.5 points for the three months ended September 30, 2025 as compared with the same period in 2024 due to a 5.9 point improvement in the loss ratio and a 1.6 point improvement in the expense ratio. The improvement in the loss ratio was primarily due to lower catastrophes losses partially offset by an increase in the underlying loss ratio related to social inflation impacted lines. Catastrophe losses were $39 million, or 2.7 points of the loss ratio, for the three months ended September 30, 2025, as compared with $127 million, or 9.6 points of the loss ratio, for the three months ended September 30, 2024. The improvement in the expense ratio was primarily driven by a lower acquisition ratio and higher net earned premiums.
Favorable net prior year loss reserve development of $1 million and $3 million was recorded for the three months ended September 30, 2025 and 2024. Further information on net prior year loss reserve development is in Note E to the Condensed Consolidated Financial Statements included under Part I, Item 1.
54
Table of Contents
Nine Month Comparison
Gross written premiums for Commercial increased $327 million for the nine months ended September 30, 2025 as compared with the same period in 2024 driven by favorable renewal premium change, inclusive of rate, partially offset by lower retention. Net written premiums for Commercial increased $295 million for the nine months ended September 30, 2025 as compared with the same period in 2024. The increase in net earned premiums was consistent with the trend in net written premiums.
Core income increased $111 million for the nine months ended September 30, 2025 as compared with the same period in 2024, primarily driven by lower catastrophe losses, improved underlying underwriting results and higher net investment income partially offset by unfavorable net prior year loss reserve development.
The combined ratio of 96.1% improved 2.2 points for the nine months ended September 30, 2025 as compared with the same period in 2024 due to a 1.2 point improvement in the expense ratio and a 1.0 point improvement in the loss ratio. The improvement in the expense ratio was driven by higher net earned premiums and a lower acquisition ratio. The improvement in the loss ratio was due to lower catastrophe losses partially offset by unfavorable net prior year loss reserve development and an increase in the underlying loss ratio related to social inflation impacted lines. Catastrophe losses were $182 million, or 4.3 points of the loss ratio, for the nine months ended September 30, 2025, as compared with $285 million, or 7.5 points of the loss ratio, for the nine months ended September 30, 2024.
Unfavorable net prior year loss reserve development of $46 million was recorded for the nine months ended September 30, 2025 as compared with $11 million of favorable net prior year loss reserve development recorded for the nine months ended September 30, 2024. Further information on net prior year loss reserve development is in Note E to the Condensed Consolidated Financial Statements included under Part I, Item 1.
The following table summarizes the gross and net carried reserves for Commercial.
(In millions)
September 30, 2025
December 31, 2024
Gross case reserves
$
4,027
$
3,690
Gross IBNR reserves
8,126
7,646
Total gross carried claim and claim adjustment expense reserves
$
12,153
$
11,336
Net case reserves
$
3,440
$
3,135
Net IBNR reserves
7,148
6,804
Total net carried claim and claim adjustment expense reserves
$
10,588
$
9,939
55
Table of Contents
International
The following table details the results of operations for International and provides the components to reconcile the combined ratio and loss ratio to the underlying combined ratio and underlying loss ratio.
Periods ended September 30
Three Months
Nine Months
(In millions, except ratios, rate, renewal premium change and retention)
2025
2024
2025
2024
Gross written premiums
$
322
$
305
$
1,132
$
1,096
Net written premiums
319
277
976
896
Net earned premiums
344
311
978
937
Underwriting gain
28
12
66
58
Net investment income
42
32
114
95
Core income
47
36
137
117
Other performance metrics:
Loss ratio
59.1
%
62.5
%
60.3
%
60.6
%
Expense ratio
32.7
33.6
32.9
33.1
Combined ratio
91.8
%
96.1
%
93.2
%
93.7
%
Less: Effect of catastrophe impacts
0.6
5.1
1.8
3.0
Less: Effect of (favorable) unfavorable development-related items
—
(0.7)
—
(0.5)
Underlying combined ratio
91.2
%
91.7
%
91.4
%
91.2
%
Underlying loss ratio
58.5
%
58.1
%
58.5
%
58.1
%
Rate
(6)
%
(2)
%
(4)
%
—
%
Renewal premium change
(3)
1
(1)
2
Retention
83
82
85
81
New business
$
94
$
73
$
280
$
213
Three Month Comparison
Gross written premiums for International increased $17 million for the three months ended September 30, 2025 as compared with the same period in 2024. Excluding the effect of foreign currency exchange rates, gross written premiums increased $9 million driven by higher new business partially offset by lower rate. Net written premiums for International increased $42 million for the three months ended September 30, 2025 as compared with the same period in 2024. Excluding the effect of foreign currency exchange rates, net written premiums increased $33 million for the three months ended September 30, 2025 as compared with the same period in 2024 driven by a true-up due to a reduction in anticipated reinsurance costs for prior treaty terms in the third quarter of 2025. The increase in net earned premiums was consistent with the trend in net written premiums in recent quarters.
Core income increased $11 million for the three months ended September 30, 2025 as compared with the same period in 2024 primarily driven by lower catastrophe losses and higher net investment income.
The combined ratio of 91.8% improved 4.3 points for the three months ended September 30, 2025 as compared with the same period in 2024 due to a 3.4 point improvement in the loss ratio and a 0.9 point improvement in the expense ratio. The improvement in the loss ratio was primarily driven by lower catastrophe losses, partially offset by no net prior year loss reserve development recorded in the current year period compared with $2 million of favorable net prior year loss reserve development in the same period in 2024, and an increase in the underlying loss ratio. Catastrophe losses were $2 million, or 0.6 points of the loss ratio, for the three months ended September 30, 2025, as compared with $16 million, or 5.1 points of the loss ratio, for the three months ended September 30, 2024. The improvement in the expense ratio was primarily driven by higher net earned premiums.
Further information on net prior year loss reserve development is in Note E to the Condensed Consolidated Financial Statements included under Part I, Item 1.
56
Table of Contents
Nine Month Comparison
Gross written premiums for International increased $36 million for the nine months ended September 30, 2025 as compared with the same period in 2024. Excluding the effect of foreign currency exchange rates, gross written premiums increased $38 million driven by higher new business and retention partially offset by lower rate. Net written premiums for International increased $80 million for the nine months ended September 30, 2025 as compared with the same period in 2024. Excluding the effect of foreign currency exchange rates, net written premiums increased $77 million for the nine months ended September 30, 2025 as compared with the same period in 2024 driven by a true-up due to a reduction in anticipated reinsurance costs for prior treaty terms in the third quarter of 2025. The increase in net earned premiums was consistent with the trend in net written premiums in recent quarters.
Core income increased $20 million for the nine months ended September 30, 2025 as compared with the same period in 2024 primarily driven by higher net investment income, lower catastrophe losses and a favorable impact from changes in foreign currency exchange rates.
The combined ratio of 93.2% improved 0.5 points for the nine months ended September 30, 2025 as compared with the same period in 2024 due to a 0.3 point improvement in the loss ratio and a 0.2 point improvement in the expense ratio. The improvement in the loss ratio was primarily driven by lower catastrophe losses, partially offset by no net prior year loss reserve development recorded in the current year period compared with $5 million of favorable net prior year loss reserve development in the same period in 2024. Catastrophe losses were $18 million, or 1.8 points of the loss ratio, for the nine months ended September 30, 2025, as compared with $28 million, or 3.0 points of the loss ratio, for the nine months ended September 30, 2024. The improvement in the expense ratio was primarily driven by higher net earned premiums.
Further information on net prior year loss reserve development is in Note E to the Condensed Consolidated Financial Statements included under Part I, Item 1.
The following table summarizes the gross and net carried reserves for International.
(In millions)
September 30, 2025
December 31, 2024
Gross case reserves
$
967
$
876
Gross IBNR reserves
2,348
2,044
Total gross carried claim and claim adjustment expense reserves
$
3,315
$
2,920
Net case reserves
$
839
$
741
Net IBNR reserves
1,964
1,675
Total net carried claim and claim adjustment expense reserves
$
2,803
$
2,416
57
Table of Contents
Life & Group
The following table summarizes the results of operations for Life & Group.
Periods ended September 30
Three Months
Nine Months
(In millions)
2025
2024
2025
2024
Net earned premiums
$
106
$
110
$
318
$
329
Claims, benefits and expenses
365
367
1,040
1,063
Net investment income
226
240
687
710
Core loss
(22)
(9)
(15)
(5)
Three Month Comparison
Core loss increased $13 million for the three months ended September 30, 2025 as compared with the same period in 2024 primarily due to lower net investment income from limited partnerships. Both periods include assumption updates as a result of the annual reserve reviews.
The cash flow assumption updates from the annual reserve review for the three months ended September 30, 2025 and 2024 resulted in a pretax increase in long-term care reserves of $7 million and $15 million.
The annual structured settlement reserve review resulted in a pretax increase in claim reserves of $2 million for the three months ended September 30, 2025 and a reduction in claim reserves of $9 million for the three months ended September 30, 2024.
Nine Month Comparison
Results for the nine months ended September 30, 2025 were generally consistent with the three month summary above.
Future Policy Benefit Reserves
Annually in the third quarter, an actuarial analysis is performed on policyholder morbidity, persistency, premium rate actions and expense experience. This analysis, combined with judgment, informs the setting of updated cash flow assumptions used to estimate the liability for future policyholder benefits (LFPB). See Note A to the Consolidated Financial Statements within CNAF's Annual Report on Form 10-K for the year ended December 31, 2024 for further information on the long-term care reserving process.
The table below summarizes the estimated pretax impact on our results of operations from various hypothetical revisions to our LFPB reserve assumptions. We have assumed that revisions to such assumptions would occur in each policy type, age and duration within each long-term care product. The impact of each sensitivity is discrete and does not reflect the impact one factor may have on another or the mitigating impact from management actions, which may include additional future premium rate increases. Although such hypothetical revisions are not currently required or anticipated, we believe they could occur based on past variances in experience and our expectations of the ranges of future experience that could reasonably occur. Any actual adjustment would be dependent on the specific policies affected and, therefore, may differ from the estimates summarized below. The estimated impacts to results of operations in the table below are after consideration of any net premium ratio impacts.
58
Table of Contents
September 30, 2025
Estimated reduction to pretax income
Hypothetical revisions (In millions)
Morbidity:
2.5% increase in morbidity
$
300
5% increase in morbidity
620
Persistency:
5% decrease in active life mortality and lapse
$
180
10% decrease in active life mortality and lapse
350
Premium Rate Actions:
25% decrease in anticipated future premium rate increases
$
30
50% decrease in anticipated future premium rate increases
50
The following table summarizes policyholder reserves for Life & Group.
September 30, 2025
(In millions)
Claim and claim adjustment expenses
Future policy benefits
Total
Long term care
$
—
$
13,546
$
13,546
Structured settlements and other
538
—
538
Total
538
13,546
14,084
Ceded reserves
77
—
77
Total gross reserves
$
615
$
13,546
$
14,161
December 31, 2024
(In millions)
Claim and claim adjustment expenses
Future policy benefits
Total
Long term care
$
—
$
13,158
$
13,158
Structured settlements and other
541
—
541
Total
541
13,158
13,699
Ceded reserves
81
—
81
Total gross reserves
$
622
$
13,158
$
13,780
As part of the annual reserve review, statutory long-term care reserve adequacy is evaluated via premium deficiency testing, by comparing carried statutory reserves with our best estimate reserves, which incorporates best estimate discount rate and liability assumptions in its determination. Statutory margin is the excess of carried reserves over best estimate reserves. As of September 30, 2025, statutory long term care margin increased to $1.5 billion from $1.4 billion.
59
Table of Contents
Corporate & Other
The following table summarizes the results of operations for the Corporate & Other segment, including intersegment eliminations.
Periods ended September 30
Three Months
Nine Months
(In millions)
2025
2024
2025
2024
Net investment income
$
16
$
14
$
45
$
53
Insurance claims and policyholders' benefits
(10)
16
107
35
Interest expense
36
32
99
101
Core loss
(25)
(44)
(175)
(119)
Three Month Comparison
Core loss improved $19 million for the three months ended September 30, 2025 as compared with the same period in 2024. The improvement was primarily due to no net prior year loss reserve development in the current year as compared with a $17 million after-tax charge in the prior year period related to unfavorable prior year loss reserve development largely associated with legacy mass tort abuse reserves.
Further information on net prior year loss reserve development is in Note E to the Condensed Consolidated Financial Statements included under Part I, Item 1.
Nine Month Comparison
Core loss increased $56 million for the nine months ended September 30, 2025 as compared with the same period in 2024 primarily due to a $106 million after-tax charge related to unfavorable net prior year loss reserve development associated with legacy mass tort abuse reserves as compared with a $45 million after-tax charge in the prior year period. Further information on net prior year loss reserve development is in Note E to the Condensed Consolidated Financial Statements included under Part I, Item 1.
The following table summarizes the gross and net carried reserves for Corporate & Other.
(In millions)
September 30, 2025
December 31, 2024
Gross case reserves
$
1,225
$
1,241
Gross IBNR reserves
1,448
1,431
Total gross carried claim and claim adjustment expense reserves
$
2,673
$
2,672
Net case reserves
$
119
$
120
Net IBNR reserves
368
268
Total net carried claim and claim adjustment expense reserves
$
487
$
388
60
Table of Contents
INVESTMENTS
Net Investment Income
The significant components of Net investment income are presented in the following table. Fixed income securities, as presented, include both fixed maturity securities and non-redeemable preferred stock.
Periods ended September 30
Three Months
Nine Months
(In millions)
2025
2024
2025
2024
Fixed income securities:
Taxable fixed income securities
$
506
$
490
$
1,510
$
1,446
Tax-exempt fixed income securities
44
35
114
109
Total fixed income securities
550
525
1,624
1,555
Limited partnership and common stock investments
71
80
225
226
Other, net of investment expense
17
21
55
72
Net investment income
$
638
$
626
$
1,904
$
1,853
Effective income yield for the fixed income securities portfolio
4.8
%
4.8
%
4.8
%
4.8
%
Limited partnership and common stock return for the period
2.5
%
3.1
%
8.3
%
9.4
%
Net investment income increased $12 million and $51 million for the three and nine months ended September 30, 2025 as compared with the same periods in 2024 driven by higher income from fixed income securities as a result of a larger invested asset base and favorable reinvestment rates.
Net Investment (Losses) Gains
The components of Net investment (losses) gains are presented in the following table.
Periods ended September 30
Three Months
Nine Months
(In millions)
2025
2024
2025
2024
Fixed maturity securities:
Corporate bonds and other
$
(6)
$
(17)
$
(55)
$
(38)
States, municipalities and political subdivisions
1
(1)
—
(3)
Asset-backed
(5)
(4)
(12)
(25)
Total fixed maturity securities
(10)
(22)
(67)
(66)
Non-redeemable preferred stock
4
13
10
25
Derivatives, short-term and other
(1)
(1)
—
(1)
Mortgage loans
—
—
(5)
—
Net investment losses
(7)
(10)
(62)
(42)
Income tax benefit on net investment losses
1
3
13
9
Net investment losses, after tax
$
(6)
$
(7)
$
(49)
$
(33)
Pretax net investment losses improved $3 million for the three months ended September 30, 2025 as compared with the same period in 2024.
Pretax net investment losses increased $20 million for the nine months ended September 30, 2025 as compared with the same period in 2024 driven by a lower favorable change in the fair value of non-redeemable preferred stock and higher net losses on disposals of fixed maturity securities, partially offset by lower impairment losses.
Further information on our investment gains and losses is set forth in Note C to the Condensed Consolidated Financial Statements included under Part I, Item 1.
61
Table of Contents
Portfolio Quality
The following table presents the estimated fair value and net unrealized gains (losses) of our fixed maturity securities by rating distribution.
September 30, 2025
December 31, 2024
(In millions)
Estimated Fair Value
Net Unrealized Gains (Losses)
Estimated Fair Value
Net Unrealized Gains (Losses)
U.S. Government, Government agencies and Government-sponsored enterprises
$
3,261
$
(251)
$
2,936
$
(369)
AAA
4,128
(136)
3,010
(217)
AA
6,883
(438)
6,369
(567)
A
11,162
(121)
10,260
(379)
BBB
16,510
(178)
16,757
(729)
Non-investment grade
1,758
(37)
1,779
(64)
Total
$
43,702
$
(1,161)
$
41,111
$
(2,325)
As of September 30, 2025 and December 31, 2024, 1% of our fixed maturity portfolio was rated internally. Additionally, as of September 30, 2025 and December 31, 2024, we assigned a AAA rating to $653 million and $199 million of municipal bonds that were either pre-refunded or backed by mortgage loans guaranteed by a U.S. government agency or sponsored enterprise.
The following table presents available-for-sale fixed maturity securities in a gross unrealized loss position by ratings distribution.
September 30, 2025
(In millions)
Estimated Fair Value
Gross Unrealized Losses
U.S. Government, Government agencies and Government-sponsored enterprises
$
1,959
$
281
AAA
1,367
248
AA
3,765
633
A
5,049
436
BBB
7,846
627
Non-investment grade
705
70
Total
$
20,691
$
2,295
The following table presents the maturity profile for these available-for-sale fixed maturity securities. Securities not due to mature on a single date are allocated based on weighted average life.
September 30, 2025
(In millions)
Estimated Fair Value
Gross Unrealized Losses
Due in one year or less
$
799
$
14
Due after one year through five years
5,977
281
Due after five years through ten years
5,478
594
Due after ten years
8,437
1,406
Total
$
20,691
$
2,295
62
Table of Contents
Duration
A primary objective in the management of the investment portfolio is to optimize return relative to the corresponding liabilities and respective liquidity needs. Our views on the current interest rate environment, tax regulations, asset class valuations, specific security issuer and broader industry segment conditions as well as domestic and global economic conditions, are some of the factors that enter into an investment decision. We also continually monitor exposure to issuers of securities held and broader industry sector exposures and may from time to time adjust such exposures based on our views of a specific issuer or industry sector.
A further consideration in the management of the investment portfolio is the characteristics of the corresponding liabilities and the ability to align the duration of the portfolio to those liabilities and to meet future liquidity needs, minimize interest rate risk and maintain a level of income sufficient to support the underlying insurance liabilities. For portfolios where future liability cash flows are determinable and typically long term in nature, we segregate investments for asset/liability management purposes. The segregated investments support the long-term care and structured settlement liabilities in the Life & Group segment.
The effective durations of fixed income securities and short-term investments are presented in the following table. Amounts presented are net of payable and receivable amounts for securities purchased and sold, but not yet settled.
September 30, 2025
December 31, 2024
(In millions)
Estimated Fair Value
Effective
Duration
(In years)
Estimated Fair Value
Effective
Duration
(In years)
Life & Group
$
15,679
9.8
$
14,915
9.8
Property & Casualty and Corporate & Other
30,754
4.6
28,779
4.3
Total
$
46,433
6.3
$
43,694
6.2
The investment portfolio is periodically analyzed for changes in duration and related price risk. Certain securities have duration characteristics that are variable based on market interest rates, credit spreads and other factors that may drive variability in the amount and timing of cash flows. Additionally, we periodically review the sensitivity of the portfolio to the level of foreign exchange rates and other factors that contribute to market price changes. A summary of these risks and specific analysis on changes is included in the Quantitative and Qualitative Disclosures About Market Risk included under Item 7A of our Annual Report on Form 10-K for the year ended December 31, 2024.
63
Table of Contents
LIQUIDITY AND CAPITAL RESOURCES
Cash Flows
Our primary operating cash flow sources are premiums and investment income. Our primary operating cash flow uses are payments for claims, policy benefits and operating expenses, including interest expense on corporate debt. Additionally, cash may be paid or received for income taxes.
For the nine months ended September 30, 2025, net cash provided by operating activities was $1,920 million as compared with $1,868 million for the same period in 2024. The increase in cash provided by operating activities was driven by an increase in premiums collected and higher cash from investment earnings, partially offset by an increase in net claim payments and higher operating expenses.
Cash flows from investing activities include the purchase and disposition of financial instruments, excluding those held as trading, and may include the purchase and sale of businesses, equipment and other assets not generally held for resale.
For the nine months ended September 30, 2025, net cash used by investing activities was $1,446 million as compared with $762 million for the same period in 2024. Net cash provided or used by investing activities is primarily driven by cash available from operations and by other factors, such as financing activities.
Cash flows from financing activities may include proceeds from the issuance of debt and equity securities, and outflows for stockholder dividends, repayment of debt and purchases of our common stock.
For the nine months ended September 30, 2025, net cash used by financing activities was $478 million as compared with $998 million for the same period in 2024. Financing activities for the periods presented include:
•
During the nine months ended September 30, 2025, we paid dividends of $922 million and repurchased 700,000 shares of our common stock at an aggregate cost of $34 million.
•
In the third quarter of 2025, we issued $500 million of 5.20% notes due August 15, 2035.
•
During the nine months ended September 30, 2024, we paid dividends of $906 million and repurchased 450,000 shares of common stock at an aggregate cost of $20 million.
•
In the second quarter of 2024, we repaid the $550 million outstanding aggregate principal balance of our 3.95% senior notes which came due May 15, 2024.
•
In the first quarter of 2024, we issued $500 million of 5.125% notes due February 15, 2034.
64
Table of Contents
Common Stock Dividends
Cash dividends of $3.38 per share on our common stock, including a special cash dividend of $2.00 per share, were declared and paid during the nine months ended September 30, 2025. On October 31, 2025, our Board of Directors declared a quarterly cash dividend of $0.46 per share, payable December 4, 2025 to stockholders of record on November 17, 2025. The declaration and payment of future dividends to holders of our common stock will be at the discretion of our Board of Directors and will depend on many factors, including our earnings, financial condition, business needs and regulatory constraints.
Liquidity
We believe that our present cash flows from operating, investing and financing activities are sufficient to fund our current and expected working capital and debt obligation needs and we do not expect this to change in the near term. There are currently no amounts outstanding under our $250 million senior unsecured revolving credit facility and no borrowings outstanding through our membership in the Federal Home Loan Bank of Chicago (FHLBC).
Dividends from Continental Casualty Company (CCC) are subject to the insurance holding company laws of the State of Illinois, the domiciliary state of CCC. Under these laws, ordinary dividends, or dividends that do not require prior approval by the Illinois Department of Insurance, are determined based on the greater of the prior year's statutory net income or 10% of statutory surplus as of the end of the prior year, as well as timing and amount of dividends paid in the preceding twelve months. Additionally, ordinary dividends may only be paid from earned surplus, which is calculated by removing unrealized gains from unassigned surplus. As of September 30, 2025 CCC was in a positive earned surplus position. CCC paid dividends of $755 million and $635 million to CNAF during the nine months ended September 30, 2025 and 2024. The actual level of dividends paid in any year is determined after an assessment of available dividend capacity, holding company liquidity and cash needs as well as the impact the dividends will have on the statutory surplus of the applicable insurance company.
We have an effective shelf registration statement on file with the Securities and Exchange Commission under which we may publicly issue an unspecified amount of debt, equity or hybrid securities from time to time.
65
Table of Contents
ACCOUNTING STANDARDS UPDATE
For a discussion of Accounting Standards, see Note A to the Condensed Consolidated Financial Statements included under Part I, Item 1.
RECENT LEGISLATION
On July 4, 2025, H.R. 1, “An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14,” commonly referred to as the One Big Beautiful Bill Act (OBBBA), was enacted. The OBBBA includes significant federal tax law changes which, among other impacts, modify and make permanent certain business tax provisions originally enacted in the 2017 Tax Cuts and Jobs Act. The provisions of the OBBBA have not had a material impact on our results of operations or financial condition. The OBBBA is subject to further clarification from the issuance of future technical guidance by the U.S. Department of Treasury.
FORWARD-LOOKING STATEMENTS
This report contains a number of forward-looking statements which relate to anticipated future events rather than actual present conditions or historical events. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and generally include words such as “believes,” “expects,” “intends,” “anticipates,” “estimates” and similar expressions. Forward-looking statements in this report include any and all statements regarding expected developments in our insurance business, including losses and loss reserves (note that loss reserves for long-term care, A&EP and other mass tort claims are more uncertain, and therefore more difficult to estimate than loss reserves respecting traditional property and casualty exposures); the impact of routine ongoing insurance reserve reviews we conduct; our expectations concerning our revenues, earnings, expenses and investment activities; volatility in investment returns; and our proposed actions in response to trends in our business. Forward-looking statements, by their nature, are subject to a variety of inherent risks and uncertainties that could cause actual results to differ materially from the results projected in the forward-looking statements. We cannot control many of these risks and uncertainties. These risks and uncertainties include, but are not limited to, the following as well as those risks contained in the Risk Factors section of our 2024 Annual Report on Form 10-K:
Company-Specific Factors
•
the risks and uncertainties associated with our insurance reserves, as outlined in the Critical Accounting Estimates sections of our 2024 Annual Report on Form 10-K and this report, and the Reserves - Estimates and Uncertainties section of our 2024 Annual Report on Form 10-K, including the sufficiency of the reserves and the possibility of future increases, which would be reflected in the results of operations in the period that the need for such adjustment is determined;
•
the risk that the other parties to the transactions in which, subject to certain limitations, we ceded our legacy A&EP and excess workers' compensation (EWC) liabilities, respectively, will not fully perform their respective obligations to CNA, the uncertainty in estimating loss reserves for A&EP and EWC liabilities and the possible continued exposure of CNA to liabilities for A&EP and EWC claims that are not covered under the terms of the respective transactions; and
•
the performance of reinsurance companies under reinsurance contracts with us.
Industry and General Market Factors
•
general economic and business conditions, including potential recessionary conditions that may decrease the size and number of our insurance customers and create losses in our lines of business, and inflationary pressures on medical care costs, construction costs and other economic sectors;
•
the effect of changes in tariffs, as well as significant uncertainty surrounding U.S. tariff policy generally, may adversely impact the economic environment, inflation expectations and certain loss costs (that would increase the cost of claims) and may result in decreases in the size and number of our insurance customers, in addition to potentially adversely affecting the performance of our investments;
•
the effects of social inflation, including frequency of nuclear verdicts and increased litigation activity, on the severity of claims;
•
the effects on the frequency of claims of reviver statutes that extend, or eliminate, the statute of limitations for the reporting of claims, including statutes passed in certain states with respect to sexual abuse;
•
the impact of competitive products, policies and pricing and the competitive environment in which we operate, including changes in our book of business;
66
Table of Contents
•
product and policy availability and demand and market responses, including the level of ability to obtain rate increases;
•
the COVID-19 pandemic, other potential pandemics and related measures to mitigate the spread of the foregoing may continue to result in increased claims and related litigation risk across our enterprise;
•
conditions in the capital and credit markets, including uncertainty and instability in these markets, as well as the overall economy, and their impact on the returns, types, liquidity and valuation of our investments;
•
conditions in the capital and credit markets that may limit our ability to raise significant amounts of capital on favorable terms or at all; and
•
the possibility of changes in our ratings by ratings agencies, including the inability to access certain markets or distribution channels and the required collateralization of future payment obligations as a result of such changes, and changes in rating agency policies and practices.
Regulatory, Legal and Operational Factors
•
regulatory and legal initiatives and compliance with governmental regulations and other legal requirements, which are increasing in complexity and number, change frequently, sometimes conflict, and could expose us to significant monetary damages, regulatory enforcement actions, fines and/or criminal prosecution in one or more jurisdictions, including regulations related to cybersecurity protocols (which continue to evolve in breadth, sophistication and maturity in response to an ever-evolving threat landscape) or utilization of artificial intelligence, legal inquiries by state authorities, judicial interpretations within the regulatory framework, including interpretation of policy provisions, decisions regarding coverage and theories of liability, legislative actions that increase claimant activity, including those revising applicability of statutes of limitations, trends in litigation and the outcome of any litigation involving us and rulings and changes in tax laws and regulations;
•
regulatory limitations, impositions and restrictions upon us, including with respect to our ability to increase premium rates, and the effects of assessments and other surcharges for guaranty funds and second-injury funds, other mandatory pooling arrangements and future assessments levied on insurance companies;
•
regulatory limitations and restrictions, including limitations upon our ability to receive dividends from our insurance subsidiaries, imposed by regulatory authorities, including regulatory capital adequacy standards;
•
breaches of our or our vendors' data security infrastructure resulting in unauthorized access to systems and information, and/or interruption of operations; and
•
regulatory and legal implications relating to the sophisticated cyber incident sustained by the Company in March 2021, or any future cyber incidents, that may arise.
Impact of Natural and Man-Made Disasters and Mass Tort Claims
•
weather and other natural physical events, including the severity and frequency of storms, hail, snowfall and other winter conditions, natural disasters such as hurricanes, tornados and earthquakes, as well as climate change, including effects on global weather patterns, greenhouse gases, sea, land and air temperatures, sea levels, wildfires, rain, hail and snow;
•
regulatory requirements imposed by coastal state regulators in the wake of hurricanes or other natural disasters, including limitations on the ability to exit markets or to non-renew, cancel or change terms and conditions in policies, as well as mandatory assessments to fund any shortfalls arising from the inability of quasi-governmental insurers to pay claims;
•
man-made disasters, including the possible occurrence of terrorist attacks, the unpredictability of the nature, targets, severity or frequency of such events, and the effect of the absence or insufficiency of applicable terrorism legislation on coverages;
•
the occurrence of epidemics and pandemics; and
•
mass tort claims, including those related to exposure to potentially harmful products or substances such as glyphosate, lead paint, per- and polyfluoroalkyl substances (PFAS) and opioids, sexual abuse and molestation claims and claims arising from changes that repeal or weaken tort reforms.
Our forward-looking statements speak only as of the date of the filing of this Quarterly Report on Form 10-Q and we do not undertake any obligation to update or revise any forward-looking statement to reflect events or circumstances after the date of the statement, even if our expectations or any related events or circumstances change.
67
Table of Contents
Item 3. Quantitative and Qualitative Disclosures About Market Risk
There were no material changes in our market risk components for the three months ended September 30, 2025. See the Quantitative and Qualitative Disclosures About Market Risk included in Item 7A of our Annual Report on Form 10-K for the year ended December 31, 2024 for further information. Additional information related to portfolio duration is discussed in the Investments section of our Management's Discussion and Analysis of Financial Condition and Results of Operations included in Part I, Item 2.
Item 4. Controls and Procedures
The Company maintains a system of disclosure controls and procedures which are designed to ensure that information required to be disclosed by the Company in reports that it files or submits to the Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), including this report, is recorded, processed, summarized and reported on a timely basis. These disclosure controls and procedures include controls and procedures designed to ensure that information required to be disclosed under the Exchange Act is accumulated and communicated to the Company's management on a timely basis to allow decisions regarding required disclosure.
As of September 30, 2025, the Company's management, including the Company's Chief Executive Officer (CEO) and Chief Financial Officer (CFO), conducted an evaluation of the effectiveness of the Company's disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)). Based on this evaluation, the CEO and CFO have concluded that the Company's disclosure controls and procedures are effective as of September 30, 2025.
There has been no change in the Company’s internal control over financial reporting (as defined in Rules 13a-15
(f) and 15d-15(f) under the Exchange Act) during the quarter ended September 30, 2025 that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.
68
Table of Contents
PART II. Other Information
Item 1. Legal Proceedings
Information on our legal proceedings is set forth in Note G to the Condensed Consolidated Financial Statements included under Part I, Item 1.
Item 6. Exhibits
See Exhibit Index.
69
Table of Contents
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
CNA Financial Corporation
Dated: November 3, 2025
By
/s/ Scott R. Lindquist
Scott R. Lindquist
Executive Vice President and
Chief Financial Officer
(Duly authorized officer and principal financial officer)
70
Table of Contents
EXHIBIT INDEX
Description of Exhibit
Exhibit Number
Certification of Chief Executive Officer
31.1
Certification of Chief Financial Officer
31.2
Written Statement of the Chief Executive Officer of CNA Financial Corporation Pursuant to 18 U.S.C. Section 1350 (As adopted by Section 906 of the Sarbanes-Oxley Act of 2002)
32.1
Written Statement of the Chief Financial Officer of CNA Financial Corporation Pursuant to 18 U.S.C. Section 1350 (As adopted by Section 906 of the Sarbanes-Oxley Act of 2002)
32.2
XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
101.INS
Inline XBRL Taxonomy Extension Schema
101.SCH
Inline XBRL Taxonomy Extension Calculation Linkbase
101.CAL
Inline XBRL Taxonomy Extension Definition Linkbase
101.DEF
Inline XBRL Taxonomy Label Linkbase
101.LAB
Inline XBRL Taxonomy Extension Presentation Linkbase
101.PRE
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
104.1
71